INTEL CORP
SC 13D, 1997-03-27
SEMICONDUCTORS & RELATED DEVICES
Previous: FLEET FINANCIAL GROUP INC, 10-K405, 1997-03-27
Next: AMERICAN BANKNOTE CORP, 10-K, 1997-03-27



               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549
                                
                          SCHEDULE 13D
                                
            Under the Securities Exchange Act of 1934
                                
                STANDARD MICROSYSTEMS CORPORATION
                        (Name of Issuer)
                                
                          Common Stock
                 (Title of Class of Securities)
                                
                           853626-10-9
                         (CUSIP Number)
                                
                         Peter N. Detkin
        Acting General Counsel and Director of Litigation
                        Intel Corporation
                 2200 Mission College Boulevard
                      Santa Clara, CA 95052
                    Telephone: (408) 765-8080
          (Name, Address and Telephone Number of Person
        Authorized to Receive Notices and Communications)
                                
                         March 18, 1997
                  (Date of Event which Requires
                    Filing of this Statement)
                                
If the filing person has previously filed a statement on Schedule
13G  to  report  the  acquisition which is the  subject  of  this
Schedule  13D, and is filing this schedule because of Rule  13d-1
(b)(3) or (4), check the following box [ ].

The  information  required on the remainder of  this  cover  page
shall  not be deemed to be "filed" for the purpose of Section  18
of  the  Securities  Exchange Act of 1934  ("Act")  or  otherwise
subject  to the liabilities of that section of the Act but  shall
be subject to all other provisions of the Act.

<PAGE>                    Schedule 13D         Page 2 of 14 Pages

1.   NAME OF REPORTING PERSON                      Intel
                                                   Corporation
     S.S.  OR  I.R.S. IDENTIFICATION NO. OF  ABOVE 94-1672743
     PERSON
                                                   
2.   CHECK  THE APPROPRIATE BOX IF A MEMBER  OF  A     (a) [   ]
     GROUP                                             (b) [   ]
                                                   
3.   SEC USE ONLY                                  
                                                   
4.   SOURCE OF FUNDS                               WC
                                                   
5.   CHECK  BOX IF DISCLOSURE OF LEGAL PROCEEDINGS         [   ]
     IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
                                                   
6.   CITIZENSHIP OR PLACE OF ORGANIZATION          Delaware
                                                   
  NUMBER OF   7.     SOLE VOTING POWER             3,085,112
   SHARES                                          
BENEFICIALLY  8.     SHARED VOTING POWER           N/A
  OWNED BY                                         
    EACH      9.     SOLE DISPOSITIVE POWER        3,085,112
  REPORTING                                        
 PERSON WITH  10.    SHARED DISPOSITIVE POWER      N/A
                                                   
11.  AGGREGATE AMOUNT BENEFICIALLY OWNED  BY  EACH 3,085,112
     REPORTING PERSON
                                                   
12.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)          [   ]
     EXCLUDES CERTAIN SHARES
                                                   
13.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW          18.2%
     (11)
                                                   
14.  TYPE OF REPORTING PERSON                                  CO

<PAGE>                    Schedule 13D         Page 3 of 14 Pages

Item 1.   Security and Issuer.
                 
          (a)    Name and Address of Principal Executive Offices
                 of Issuer:
                 Standard Microsystems Corporation
                 80 Arkay Drive
                 Hauppauge, New York 11788
                 
          (b)    Title and Class of        
                 Equity Securities:        Common Stock
                 
Item 2.   Identity and Background
                 
          (a)    Name of Person Filing:    Intel Corporation
                 
                                           The executive
                                           officers and
                                           directors of Intel
                                           Corporation are set
                                           forth on Appendix A
                                           hereto.
                                           
          (b)    State of Incorporation:   Delaware
                                           
          (c)    Principal Business:       Manufacturer of
                                           microcomputer
                                           components, modules
                                           and systems
                 
          (d)    Address of Principal Business and Principal
                 Office:
                 
                 2200 Mission College Boulevard
                 Santa Clara, CA 95052-8119
                 
          (e)    Criminal Proceedings:
                 
                 During the last five years neither the
                 Reporting Person nor any officer or director of
                 the Reporting Person has been convicted in any
                 criminal proceeding.
                 
          (f)    Civil Proceedings:
                 
                 During the last five years neither the
                 Reporting Person nor any officer or director of
                 the Reporting Person has been party to any
                 civil proceeding of a judicial or
                 administrative body of competent jurisdiction
                 as a result of which such person would have
                 been subject to any judgment, decree or final
                 order enjoining future violations of or
                 prohibiting or mandating activities subject to
                 Federal or State securities laws or finding any
                 violation with respect to such laws.

<PAGE>                    Schedule 13D         Page 4 of 14 Pages
                 
Item 3.   Source and Amount of Funds or Other Consideration.
                 
          Funds for the purchase of the securities are derived
          from the Reporting Person's working capital.
          $14,653,807 was paid to acquire 1,542,506 shares of
          Common Stock of the Issuer.  Additional amounts, which
          vary depending on the date of exercise, will be paid
          should the Reporting Person exercise the Warrant (as
          defined in Item 4).
                                                                 
Item 4.   Purpose of the Transaction
                 
          The Reporting Person acquired the Common Stock and the
          Warrant  (as  described in Item  5(c),  below)  as  an
          investment   and  in  connection  with  a   technology
          agreement between the Issuer and the Reporting  Person
          pursuant to which the Issuer and Reporting Person will
          work   cooperatively   on  the  integration   of   new
          semiconductor  input/output (I/O) integrated  circuits
          into  selected  personal computer motherboard  designs
          and  also on a family of proprietary low-pin-count I/O
          devices for future applications.  In addition  to  the
          1,542,506  shares  of  Common  Stock  of  the   Issuer
          acquired by the Reporting Person, the Reporting Person
          also acquired a warrant (the "Warrant") to purchase up
          to  1,542,606  shares of Common Stock of  the  Issuer.
          The  shares of Common Stock subject to the Warrant are
          vested  and  immediately exercisable .   The  exercise
          price for the shares increases periodically throughout
          the time that the Warrant is in effect, pursuant to  a
          schedule  set  forth  in  the  Warrant.   The  Warrant
          expires on March 18, 2000.
                 
Item 5.   Interests in Securities of the Issuer.
                 
          (a)    Number of Shares        3,085,112 shares*
                 Beneficially Owned:
                                         
                 Right to Acquire:       1,542,606 shares*
                                         
                 Percent of Class:       18.2%*   (based    upon
                                         16,968,569  shares*  of
                                         common            stock
                                         outstanding, determined
                                         from    representations
                                         made  by the Issuer  to
                                         the Reporting Person in
                                         connection   with   the
                                         closing    under    the
                                         Purchase Agreement  (as
                                         defined below)
                 
- -----------------------
*  Includes  the additional shares (up to 1,542,606)  of  Common
Stock  that the Reporting Person has a right to acquire pursuant
to  the  Warrant  (as defined and described in  Item  4).   Such
shares are beneficially owned by the Reporting Person under Rule
13d-3  because the Reporting Person has a right to acquire  such
shares within the next 60 days.

<PAGE>                    Schedule 13D         Page 5 of 14 Pages
                                         
          (b)    Sole Power to Vote,     
                 Direct the Vote of, or  
                 Dispose of Shares:      3,085,112 shares*
                                         
                 Shared Power to Vote,   
                 Direct the Vote of, or  
                 Dispose of Shares:      None
                 
          (c)    Recent Transactions:
                 
                 On  March  18, 1997, pursuant to the  terms  of
                 that  certain Common Stock and Warrant Purchase
                 Agreement  dated  as  of March  18,  1997  (the
                 "Purchase  Agreement"),  the  Reporting  Person
                 purchased (i) 1,542,506 newly issued shares of

                 Common Stock of the Issuer at a price per share
                 of  $9.50, and (ii) the Warrant to purchase  up
                 to  1,542,606 shares of Common Stock.  See  the
                 Purchase  Agreement and the  Warrant,  each  of
                 which has been filed as an Exhibit hereto,  for
                 additional details.
                 
          (d)    Rights with Respect to Dividends or     
                 Sales Proceeds:                         N/A
                                                         
          (e)    Date of Cessation of Five Percent       
                 Beneficial Ownership:                   N/A
                 
Item 6.   Contracts,     Arrangements,     Understandings     or
          Relationships  With  Respect  to  Securities  of   the
          Issuer.
                 
          Pursuant to the Investor Rights Agreement between  the
          Reporting Person and the Issuer, the Reporting  Person
          has,   under  certain  circumstances,  various  rights
          related  to (a) registration of the Common Stock  that
          the Reporting Person owns, (b) participation in future
          sales  and issuances of securities by the Issuer,  (c)
          maintaining  its ownership percentage in  the  Issuer,
          (d) receiving various public filings directly from the
          Issuer on a periodic basis, and (e) the opportunity to
          acquire the Issuer or certain assets of the Issuer  if
          the  Issuer  seeks  other offers or  receives  certain
          unsolicited offers.  The Reporting Person has  certain
          standstill obligations relating to its acquisition  of
          shares  of  Common  Stock of the  Issuer  and  certain
          restrictions  on  its  voting  rights.   The  Purchase
          Agreement   also  contains  certain  restrictions   on
          transfer of the Common Stock by the Reporting  Person.
          See  the  Investor Rights Agreement,  attached  as  an
          Exhibit  hereto,  for a further description  of  these
          provisions.

- -----------------------
*  Includes  the additional shares (up to 1,542,606)  of  Common
Stock  that the Reporting Person has a right to acquire pursuant
to  the  Warrant  (as defined and described in  Item  4).   Such
shares are beneficially owned by the Reporting Person under Rule
13d-3  because the Reporting Person has a right to acquire  such
shares within the next 60 days.

<PAGE>                    Schedule 13D         Page 6 of 14 Pages

Item 7.   Material to Be Filed as Exhibits.
                       
          Exhibit 1    Standard Microsystems Corporation  Common
                       Stock  and  Warrant  Purchase  Agreement,
                       dated  March  18, 1997, between  Standard
                       Microsystems   Corporation   and    Intel
                       Corporation.
                       
          Exhibit 2    Warrant  to  Purchase  Shares  of  Common
                       Stock     of     Standard    Microsystems
                       Corporation, dated March 18, 1997.
                       
          Exhibit 3    Standard     Microsystems     Corporation
                       Investor  Rights Agreement,  dated  March
                       18,  1997,  between Standard Microsystems
                       Corporation and Intel Corporation.
                       
          Exhibit 4    Press  Release  of Standard  Microsystems
                       Corporation, dated March 18, 1997.

          Exhibit 5    Signature Authority

<PAGE>                    Schedule 13D         Page 7 of 14 Pages

                            SIGNATURE
                                
After  reasonable  inquiry and to the best of  my  knowledge  and
belief,  I  certify  that  the  information  set  forth  in  this
statement is true, complete and correct.

Dated as of March 27, 1997.      
                                 
                                 INTEL CORPORATION
                                 
                                 /s/Peter N. Detkin
                            By:  Peter N. Detkin
                                 Acting General counsel
                                 and Director of Litigation



<PAGE>                    Schedule 13D         Page 8 of 14 Pages

                           APPENDIX A
                                
                            DIRECTORS
                                
The following is a list of all Directors of Intel Corporation and
certain  other  information with respect to each  Director.   All
Directors are United States citizens.

Name:             Craig R. Barrett
                  
Business          2200 Mission College Boulevard, Santa Clara,
Address:          CA 95052
                  
Principal         Executive Vice President and Chief Operating
Occupation:       Officer of Intel Corporation
                  
Name, principal   Intel Corporation, a manufacturer of
business and      microcomputer components, modules and systems.
address of        2200 Mission College Boulevard
corporation or    Santa Clara, CA 95052
other
organization on
which employment
is conducted:
                  
                  
Name:             Winston H. Chen
                  
Business          Paramitas Foundation, 3945 Freedom Circle,
Address:          Suite 760, Santa Clara, CA 95054
                  
Principal         Chairman of Paramitas Foundation
Occupation:
                  
Name, principal   Paramitas Foundation, a charitable foundation.
business and      3945 Freedom Circle, Suite 760
address of        Santa Clara, CA 95054
corporation or
other
organization on
which employment
is conducted:
                  

<PAGE>                    Schedule 13D         Page 9 of 14 Pages

Name:             Andrew S. Grove
                  
Business          2200 Mission College Boulevard, Santa Clara,
Address:          CA 95052
                  
Principal         President and Chief Executive Officer of Intel
Occupation:       Corporation
                  
Name, principal   Intel Corporation, a manufacturer of
business and      microcomputer components, modules and systems.
address of        2200 Mission College Boulevard
corporation or    Santa Clara, CA 95052
other
organization on
which employment
is conducted:
                  
                  
Name:             D. James Guzy
                  
Business          1340 Arbor Road, Menlo Park, CA 94025
Address:
                  
Principal         Chairman of The Arbor Company
Occupation:
                  
Name, principal   The Arbor Company, a limited partnership
business and      engaged in the electronics and computer
address of        industry.
corporation or    1340 Arbor Road
other             Menlo Park, CA 94025
organization on
which employment
is conducted:
                  
                  
Name:             Gordon E. Moore
                  
Business          2200 Mission College Boulevard, Santa Clara,
Address:          CA 95052
                  
Principal         Chairman of the Board of Intel Corporation
Occupation:
                  
Name, principal   Intel Corporation, a manufacturer of
business and      microcomputer components, modules and systems.
address of        2200 Mission College Boulevard
corporation or    Santa Clara, CA 95052
other
organization on
which employment
is conducted:

<PAGE>                    Schedule 13D        Page 10 of 14 Pages

Name:             Max Palevsky
                  
Business          924 Westwood Boulevard, Suite 700, Los Angeles
Address:          CA 90024
                  
Principal         Industrialist
Occupation:
                  
Name, principal   Self-employed.
business and
address of
corporation or
other
organization on
which employment
is conducted:
                  
                  
Name:             Arthur Rock
                  
Business          One Maritime Plaza, Suite 1220, San Francisco,
Address:          CA 94111
                  
Principal         Venture Capitalist
Occupation:
                  
Name, principal   Arthur Rock and Company, a venture capital
business and      firm.
address of        One Maritime Plaza, Suite 1220
corporation or    San Francisco, CA 94111
other
organization on
which employment
is conducted:


Name:             Jane E. Shaw
                  
Business          c/o Intel Corporation, 2200 Mission College
Address:          Boulevard, Santa Clara, CA 95052
                  
Principal         Founder of The Stable Network, a
Occupation:       biopharmaceutical consulting company
                  
Name, principal   c/o Intel Corporation
business and      2200 Mission College Boulevard
address of        Santa Clara, CA 95052
corporation or
other
organization on
which employment
is conducted:

<PAGE>                    Schedule 13D        Page 11 of 14 Pages

Name:             Leslie L. Vadasz
                  
Business          2200 Mission College Boulevard, Santa Clara,
Address:          CA 95052
                  
Principal         Senior Vice President, Director, Corporate
Occupation:       Business Development, Intel Corporation
                  
Name, principal   Intel Corporation, a manufacturer of
business and      microcomputer components, modules and systems.
address of        2200 Mission College Boulevard
corporation or    Santa Clara, CA 95052
other
organization on
which employment
is conducted:
                  
                  
Name:             David B. Yoffie
                  
Business          Harvard Business School, Soldiers Field Park 1-
Address:          411, Boston, MA 92163
                  
Principal         Max and Doris Starr Professor of International
Occupation:       Business Administration
                  
Name, principal   Harvard Business School, an educational
business and      institution.
address of        Harvard Business School
corporation or    Soldiers Field Park 1-411
other             Boston, MA 92163
organization on
which employment
is conducted:
                  
                  
Name:             Charles E. Young
                  
Business          405 Hilgard Avenue, Los Angeles, CA 90024
Address:
                  
Principal         Chancellor
Occupation:
                  
Name, principal   University of California at Los Angeles, an
business and      educational institution.
address of        405 Hilgard Avenue
corporation or    Los Angeles, CA 90024
other
organization on
which employment
is conducted:

<PAGE>                    Schedule 13D        Page 12 of 14 Pages
                                                                 
                       EXECUTIVE OFFICERS
                                
The  following  is  a  list of all executive  officers  of  Intel
Corporation excluding executive officers who are also  directors.
Unless  otherwise indicated, each officer's business  address  is
2200 Mission College Boulevard, Santa Clara, CA 95052-8119, which
address  is Intel Corporation's business address.  All  executive
officers are United States citizens.

Name:       Frank C. Gill
Title:      Executive Vice President; General Manager, Internet
            and Communications Group
Address:    5200 N.E. Elam Young Parkway, Hillsboro, OR 97124-
            6497
            
Name:       Paul S. Otellini
Title:      Executive Vice President; Director, Sales and
            Marketing Group
            
Name:       Gerhard H. Parker
Title:      Executive Vice President, General Manager, Technology
            and Manufacturing Group
            
Name:       Ronald J. Whittier
Title:      Senior Vice President; General Manager, Content Group
            
Name:       Albert Y. C. Yu
Title:      Senior Vice President; General Manager,
            Microprocessor Products Group
            
Name:       Michael A. Aymar
Title:      Vice President; General Manager, Desktop Products
            Group
            
Name:       Andy D. Bryant
Title:      Vice President and Chief Financial Officer
            
Name:       G. Carl Everett, Jr.
Title:      Senior Vice President, General Manager, Desktop
            Products Group
            
Name:       F. Thomas Dunlap, Jr.
Title:      Vice President, General Counsel and Secretary
            
Name:       Patrick P. Gelsinger
Title:      Vice President, General Manager, Desktop Products
            Group
Address:    5200 N.E. Elam Young Parkway, Hillsboro, OR 97124-
            6497
            
Name:       John H. F. Miner
Title:      Vice President, General Manager, Enterprise Server
            Group
Address:    5200 N.E. Elam Young Parkway, Hillsboro, OR 97124-
            6497

<PAGE>                    Schedule 13D        Page 13 of 14 Pages

Name:       Stephen P. Nachtsheim
Title:      Vice President; General Manager, Mobile/Handheld
            Products Group
            
Name:       Ronald J. Smith
Title:      Vice President, General Manager, Computing
            Enhancement Group

<PAGE>                    Schedule 13D        Page 14 of 14 Pages


                          EXHIBIT INDEX
                                
                                                    Sequentially
                                                      Numbered
Exhibit No.  Document                                   Page
                                                          
Exhibit 1    Standard   Microsystems   Corporation      1.1
             Common  Stock  and  Warrant  Purchase
             Agreement,  dated  March  18,   1997,
             between     Standard     Microsystems
             Corporation and Intel Corporation.
                                                          
Exhibit 2    Warrant to Purchase Shares of  Common      2.1
             Stock    of   Standard   Microsystems
             Corporation, dated March 18, 1997.
                                                          
Exhibit 3    Standard   Microsystems   Corporation      3.1
             Investor   Rights  Agreement,   dated
             March   18,  1997,  between  Standard
             Microsystems  Corporation  and  Intel
             Corporation.
                                                          
Exhibit 4    Press     Release     of     Standard      4.1
             Microsystems    Corporation,    dated
             March 18, 1997.
                                                          
Exhibit 5    Signature Authority                        5.1




                            EXHIBIT 1
                                
<PAGE> 1.1
                STANDARD MICROSYSTEMS CORPORATION
                                
                    COMMON STOCK AND WARRANT
                       PURCHASE AGREEMENT
                                
This   Common   Stock  and  Warrant  Purchase   Agreement   (this
"Agreement")  is made and entered into as of March 18,  1997,  by
and   between  Standard  Microsystems  Corporation,  a   Delaware
corporation  (the "Company"), and Intel Corporation,  a  Delaware
corporation (the "Investor").

                          R E C I T A L
                          -------------
                                
WHEREAS,  the  Company desires to sell to the Investor,  and  the
Investor  desires  to purchase from the Company,  shares  of  the
Company's  Common  Stock  and a Warrant  to  purchase  additional
shares  of the Company's Common Stock on the terms and conditions
set forth in this Agreement;

NOW,  THEREFORE, in consideration of the foregoing  recital,  the
mutual  promises  hereinafter  set  forth,  and  other  good  and
valuable consideration, the receipt and sufficiency of which  are
hereby acknowledged, the parties hereto agree as follows:

1.   AGREEMENT TO PURCHASE AND SELL STOCK.

      1.1   Authorization.  The Company's Board of Directors  has
authorized the issuance, pursuant to the terms and conditions  of
this  Agreement, of up to the number of shares of  the  Company's
Common  Stock equal to ten percent (10%) of the number of  shares
of  the  Company's  Common  Stock  and  other  voting  securities
outstanding immediately following the Closing (as defined  below)
minus  100 shares ("Purchased Shares") PLUS the number of  shares
of  the Company's Common Stock equal to ten percent (10%) of  the
number  of shares of the Company's Common Stock and other  voting
securities   outstanding  immediately   following   the   Closing
("Warrant Shares").

      1.2   Agreement  to  Purchase and Sell Common  Stock.   The
Company hereby agrees to sell to the Investor at the Closing, and
the  Investor agrees to purchase from the Company at the Closing,
the  Purchased Shares at a price per share equal to the Per Share
Purchase Price.

      1.3   Per  Share  Purchase Price.  The "Per Share  Purchase
Price" shall be Nine Dollars and Fifty Cents ($9.50) (subject  to
adjustment for stock splits, stock dividends and similar events).

      1.4   Agreement to Purchase and Sell Warrant.  The  Company
hereby  agrees to issue to the Investor at the Closing a  Warrant
(the  "Warrant")  to  purchase the Warrant  Shares  in  the  form
attached hereto as Exhibit A.

<PAGE> 1.2

2    CLOSING

      2.1   The  Closing.  The purchase and sale of the Purchased
Shares  and the Warrant will take place at the offices of Gibson,
Dunn  & Crutcher, 1 Montgomery Street, Telesis Tower, Suite 3100,
San  Francisco, California, at 10:00 a.m. California time, within
three  (3)  business  days  after the  conditions  set  forth  in
Articles  5 and 6 have been satisfied, or at such other time  and
place  as the Company and the Investor mutually agree upon (which
time  and  place  are  referred  to  in  this  Agreement  as  the
"Closing").   At  the Closing, the Company will  deliver  to  the
Investor the Warrant and a certificate representing the Purchased
Shares,  all  against delivery to the Company by the Investor  of
the  full  purchase price of the Purchased Shares, paid  by  wire
transfer of funds to the Company.

3     REPRESENTATIONS AND WARRANTIES OF THE COMPANY.  The Company
hereby   represents  and  warrants  to  the  Investor  that   the
statements in this Section 3 are true and correct, except as  set
forth in the Disclosure Letter from the Company dated March   18,
1997 (the "Disclosure Letter").

      3.1   Organization,  Good Standing and Qualification.   The
Company is a corporation duly organized, validly existing and  in
good standing under the laws of the State of Delaware and has all
corporate  power  and  authority required to  (a)  carry  on  its
business  as  presently  conducted,  and  (b)  enter  into   this
Agreement,  the Investor Rights Agreement (as defined in  Section
5.8)   and  the  Warrant,  and  to  consummate  the  transactions
contemplated hereby and thereby.  The Company is qualified to  do
business  and is in good standing in each jurisdiction  in  which
the  failure to so qualify would have a Material Adverse  Effect.
As  used  in  this Agreement, "Material Adverse Effect"  means  a
material adverse effect on, or a material adverse change in, or a
group of such effects on or changes in, the business, operations,
financial condition, results of operations, prospects, assets  or
liabilities of the Company.

      3.2  Capitalization.  As of the date of this Agreement  the
capitalization of the Company is as follows:

           (a)  Preferred Stock.  A total of 1,000,000 authorized
shares  of  Preferred  Stock, $0.10  par  value  per  share  (the
"Preferred Stock"), none of which is issued or outstanding.

           (b)   Common Stock.  A total of 30,000,000  authorized
shares  of  Common Stock, $0.10 par value per share (the  "Common
Stock"),  of  which 13,883,457 shares are issued and outstanding.
All of such outstanding shares are validly issued, fully paid and
non-assessable.   No  such  outstanding  shares  were  issued  in
violation of any preemptive right.

          (c)  Options, Warrants, Reserved Shares.  Except as set
forth  in  the  Disclosure Letter, there are not outstanding  any
options,  warrants,  rights (including conversion  or  preemptive
rights)  or agreements for the purchase or acquisition  from  the
Company  of  any  shares of its capital stock or  any  securities
convertible  into or ultimately exchangeable or  exercisable  for
any  shares of the Company's capital stock.  Except for any stock
repurchase  rights of the Company under the Plans, no  shares  of
the Company's outstanding capital stock, or stock

<PAGE> 1.3

issuable upon exercise, conversion or exchange of any outstanding
options,  warrants  or  rights, or other stock  issuable  by  the
Company,  are  subject to any rights of first  refusal  or  other
rights to purchase such stock (whether in favor of the Company or
any other person), pursuant to any agreement, commitment or other
obligation of the Company.

      3.3   Subsidiaries.  The Company does not presently own  or
control,  directly  or  indirectly, any  interest  in  any  other
corporation,  partnership, trust, joint venture,  association  or
other entity.

     3.4  Due Authorization.  All corporate action on the part of
the  Company, its officers, directors and shareholders  necessary
for   the   authorization,  execution,  delivery  of,   and   the
performance  of  all  obligations  of  the  Company  under,  this
Agreement, the Investor Rights Agreement (as defined below),  and
the  Warrant,  and the authorization, issuance,  reservation  for
issuance  and delivery of all of the Purchased Shares being  sold
under this Agreement and of the Warrant Shares has been taken  or
will   be   taken  prior  to  the  Closing,  and  this  Agreement
constitutes,  and the Investor Rights Agreement and  the  Warrant
when   executed,  will  constitute,  valid  and  legally  binding
obligations  of the Company, enforceable against the  Company  in
accordance with their respective terms, except as may be  limited
by  (i)  applicable  bankruptcy,  insolvency,  reorganization  or
others  laws of general application relating to or affecting  the
enforcement of creditors' rights generally and (ii) the effect of
rules of law governing the availability of equitable remedies.

     3.5  Valid Issuance of Stock.

           (a)   The  Purchased  Shares, when  issued,  sold  and
delivered in accordance with the terms of this Agreement for  the
consideration  provided  for herein, will  be  duly  and  validly
issued,  fully paid and nonassessable.  The Warrant  Shares  have
been  duly  and validly reserved for issuance and, upon issuance,
sale and delivery in accordance with the terms of the Warrant for
the  consideration provided for therein, will be duly and validly
issued, fully paid and nonassessable.

           (b)   Assuming  the correctness of the representations
made  by  the Investor in Section 4 hereof, the Purchased Shares,
the  Warrant  and (assuming no change in applicable  law  and  no
unlawful distribution of Purchased Shares or the Warrant  by  the
Investor)  the  Warrant Shares will be issued in full  compliance
with the registration and prospectus delivery requirements of the
Securities  Act  of  1933, as amended (the  "1933  Act"),  or  in
compliance   with  applicable  exemptions  therefrom,   and   the
registration  and  qualification requirements of  all  applicable
securities laws of the states of the United States.

      3.6  Governmental Consents.  No consent, approval, order or
authorization  of,  or registration, qualification,  designation,
declaration  or  filing  with,  any  federal,  state   or   local
governmental authority on the part of the Company is required  in
connection with the consummation of the transactions contemplated
by  this  Agreement, except for the filing of such qualifications
or  filings under the 1933 Act and the regulations thereunder and
all  applicable  state  securities laws as  may  be  required  in
connection with the transactions contemplated by this

<PAGE> 1.4

Agreement.  All such qualifications and filings will, in the case
of  qualifications, be effective on the Closing and will, in  the
case of filings, be made within the time prescribed by law.

       3.7   Non-Contravention.   The  execution,  delivery   and
performance of this Agreement, the Investor Rights Agreement  and
the  Warrant by the Company, and the consummation by the  Company
of  the transactions contemplated hereby and thereby, do not  and
will  not  (i)  contravene or conflict with  the  Certificate  of
Incorporation  or  Bylaws  of  the  Company;  (ii)  constitute  a
violation  of  any  provision of any  federal,  state,  local  or
foreign  law binding upon or applicable to the Company; or  (iii)
constitute a default or require any consent under, give  rise  to
any right of termination, cancellation or acceleration of, or  to
a  loss of any benefit to which the Company is entitled under, or
result  in  the  creation or imposition of  any  lien,  claim  or
encumbrance  on any assets of the Company under, any contract  to
which  the  Company is a party or any permit, license or  similar
right  relating  to the Company or by which the  Company  may  be
bound  or  affected in such a manner as, together with all  other
such matters, would have Material Adverse Effect.

      3.8   Litigation.   There is no action,  suit,  proceeding,
claim,  arbitration  or  investigation ("Action")  pending:   (a)
against the Company, its activities, properties or assets or,  to
the  best  of  the  Company's  knowledge,  against  any  officer,
director  or  employee  of the Company in  connection  with  such
officer's, director's or employee's relationship with, or actions
taken  on  behalf  of, the Company, (b) that  seeks  to  prevent,
enjoin,  alter  or  delay the transactions contemplated  by  this
Agreement,  the Investor Rights Agreement or the Warrant.   There
is  no Action pending or, to the best of the Company's knowledge,
threatened,  or  any basis therefor, relating to the  current  or
prior  employment  of  any  of the Company's  current  or  former
employees  or  consultants,  their use  in  connection  with  the
Company's  business of any information, technology or  techniques
allegedly  proprietary to any of their former employers,  clients
or  other parties, or their obligations under any agreements with
prior employers, clients or other parties.  The Company is not  a
party  to  or  subject  to the provisions  of  any  order,  writ,
injunction, judgment or decree of any court or government  agency
or  instrumentality.   No  Action by  the  Company  is  currently
pending nor does the Company intend to initiate any Action  which
is reasonably likely to have a Material Adverse Effect.

     3.9  Invention Assignment and Confidentiality Agreement.  To
the  best  knowledge of the Company, each employee and consultant
or independent contractor of the Company whose duties include the
development  of  products or Intellectual  Property  (as  defined
below),  and  each former employee and consultant or  independent
contractor  whose duties included the development of products  or
Intellectual Property, has entered into and executed an invention
assignment and confidentiality agreement in customary form or  an
employment   or  consulting  agreement  containing  substantially
similar terms.

     3.10 Intellectual Property.

           (a)   Ownership or Right to Use.  The Company has sole
title  to and owns, or is licensed or otherwise possesses legally
enforceable  rights  to use, all patents or patent  applications,
software,  know-how,  registered or unregistered  trademarks  and
service marks and

<PAGE> 1.5

any applications therefor, registered or unregistered copyrights,
trade  names,  and  any applications therefor, trade  secrets  or
other  confidential  or  proprietary  information  ("Intellectual
Property")  necessary  to  enable the Company  to  carry  on  its
business  as  currently conducted, except  where  any  deficiency
therein  would not have a Material Adverse Effect.   The  Company
represents and warrants that it will, where the Company,  in  the
exercise  of  reasonable  judgment  deems  it  appropriate,   use
reasonable   business  efforts  to  seek  copyright  and   patent
registration,   and   other  appropriate  intellectual   property
protection, for Intellectual Property of the Company.

           (b)   Licenses; Other Agreements.  The Company is  not
currently  subject  to  any  exclusive  licenses  (whether   such
exclusivity is temporary or permanent) to any material portion of
the  Intellectual Property of the Company.  To the  best  of  the
Company's  knowledge, there are not outstanding any  licenses  or
agreements  of any kind relating to any Intellectual Property  of
the Company, except for agreements with OEM's and other customers
of  the  Company  entered  into in the  ordinary  course  of  the
Company's  business.   The Company is not obligated  to  pay  any
royalties or other payments to third parties with respect to  the
marketing, sale, distribution, manufacture, license or use of any
Intellectual Property, except as the Company may be so  obligated
in  the  ordinary course of its business or as disclosed  in  the
Company's SEC Documents (as defined below).

           (c)  No Infringement.  The Company has not violated or
infringed and is not currently violating or infringing,  and  the
Company  has  not received any communications alleging  that  the
Company (or any of its employees or consultants) has violated  or
infringed,  any  Intellectual Property of  any  other  person  or
entity,  to  the extent that any such violation or  infringement,
either  individually or together with all other  such  violations
and infringements, would have a Material Adverse Effect.

           (d)   Employees and Consultants.  To the best  of  the
Company's knowledge, no employee of or consultant to the  Company
is  in  default  under  any  term  of  any  employment  contract,
agreement or arrangement relating to Intellectual Property of the
Company  or  any non-competition arrangement, other contract,  or
any restrictive covenant relating to the Intellectual Property of
the  Company.   The Intellectual Property of the  Company  (other
than  any  Intellectual Property duly acquired or  licensed  from
third  parties)  was developed entirely by the  employees  of  or
consultants to the Company during the time they were employed  or
retained  by  the  Company,  and to the  best  knowledge  of  the
Company, at no time during conception or reduction to practice of
such Intellectual Property of the Company were any such employees
or consultants operating under any grant from a government entity
or  agency  or  subject to any employment agreement or  invention
assignment  or  non-disclosure agreement or any other  obligation
with a third party that would materially and adversely affect the
Company's  rights in the Intellectual Property  of  the  Company.
Such  Intellectual Property of the Company does not, to the  best
knowledge  of  the  Company,  include  any  invention  or   other
intellectual property of such employees or consultants made prior
to  the  time  such  employees or consultants  were  employed  or
retained  by  the  Company nor any intellectual property  of  any
previous  employer  of  such employees  or  consultants  nor  the
intellectual property of any other person or entity.

<PAGE> 1.6

     3.11 Compliance with Law and Charter Documents.  The Company
is  not  in  violation  or  default  of  any  provisions  of  its
Certificate  of  Incorporation or Bylaws, both  as  amended,  and
except for any violations that would not, either individually  or
in  the  aggregate, have a Material Adverse Effect.  The  Company
has  complied and is in compliance with all applicable  statutes,
laws,  and regulations and executive orders of the United  States
of   America  and  all  states,  foreign  countries   and   other
governmental  bodies  and agencies having jurisdiction  over  the
Company's business or properties.

      3.12  Registration  Rights.   Except  as  provided  in  the
Investor Rights Agreement effective upon the Closing, the Company
is  not  currently subject to any grant or agreement to grant  to
any person or entity any rights (including piggyback registration
rights) to have any securities of the Company registered with the
United  States Securities and Exchange Commission ("SEC") or  any
other governmental authority.

      3.13  Title  to  Property and Assets.  The  properties  and
assets of the Company are owned by the Company free and clear  of
all  mortgages, deeds of trust, liens, charges, encumbrances  and
security interests except for statutory liens for the payment  of
current taxes that are not yet delinquent and liens, encumbrances
and  security  interests  that arise in the  ordinary  course  of
business and do not affect material properties and assets of  the
Company.  With respect to the property and assets it leases,  the
Company  is  in  compliance  with such  leases  in  all  material
respects.

     3.14 SEC Documents.

          (a)  The Company has furnished to the Investor prior to
the  date hereof copies of its Annual Report on Form 10-K for the
fiscal  year ended February 29, 1996 ("Form 10-K"), its Quarterly
Reports  or  Form 10-Q for the fiscal quarters ended  August  31,
1996  and  November 30, 1996 (the "Form 10-Q's"), and  all  other
registration  statements, reports and proxy statements  filed  by
the   Company   with  the  Securities  and  Exchange   Commission
("Commission") on or after February 29, 1996 (the Form 10-K,  the
10-Q's  and  such  registration  statements,  reports  and  proxy
statements,  are  collectively referred to  herein  as  the  "SEC
Documents").   Each  of the SEC Documents, as of  the  respective
date  thereof, did not, and each of the registration  statements,
reports  and  proxy  statements filed by  the  Company  with  the
Commission  after the date hereof and prior to the  Closing  will
not,  as of the date thereof, contain any untrue statement  of  a
material fact or omit to state a material fact necessary in order
to   make   the  statements  made  therein,  in  light   of   the
circumstances  under which they were made, not  misleading.   The
Company  is  not a party to any material contract,  agreement  or
other  arrangement which was required to have been  filed  as  an
exhibit to the SEC Documents that is not so filed.

           (b)   The  Company has provided the Investor with  its
audited financial statements (the "Audited Financial Statements")
for  the  fiscal year ended February 29, 1996, and its  unaudited
financial  statements for the 9-month period ended  November  30,
1996  (the "Balance Sheet Date").  Since the Balance Sheet  Date,
the  Company  has duly filed with the Commission all registration
statements, reports and proxy statements required to be filed  by
it

<PAGE> 1.7

under  the  Securities  Exchange Act of  1934,  as  amended  (the
"Exchange  Act"),  and the 1933 Act.  The audited  and  unaudited
consolidated financial statements of the Company included in  the
SEC  Documents filed prior to the date hereof fairly present,  in
conformity with generally accepted accounting principles ("GAAP")
(except as permitted by Form 10-Q) applied on a consistent  basis
(except   as  may  be  indicated  in  the  notes  thereto),   the
consolidated   financial  position  of  the   Company   and   its
consolidated  subsidiaries  as  at  the  date  thereof  and   the
consolidated results of their operations and cash flows  for  the
periods  then ended (subject to normal year and audit adjustments
in the case of unaudited interim financial statements).

           (c)  Except as and to the extent reflected or reserved
against  in the Company's Audited Financial Statements (including
the  notes  thereto),  the  Company has no  material  liabilities
(whether   accrued  or  unaccrued,  liquidated  or  unliquidated,
secured  or  unsecured, joint or several, due or to  become  due,
vested or unvested, executory, determined or determinable)  other
than:   (i)  liabilities  incurred  in  the  ordinary  course  of
business  since  the Balance Sheet Date that are consistent  with
the  Company's past practices, (ii) liabilities with  respect  to
agreements  to  which the Investor is a party,  and  (iii)  other
Liabilities  that either individually or in the aggregate,  would
not result in a Material Adverse Effect.

      3.15  Absence of Certain Changes Since Balance Sheet  Date.
Since the Balance Sheet Date, the business and operations of  the
Company  have  been  conducted in the ordinary course  consistent
with past practice, and there has not been:

           (a)  any declaration, setting aside or payment of  any
dividend or other distribution of the assets of the Company  with
respect  to  any shares of capital stock of the Company,  or  any
repurchase, redemption or other acquisition by the Company or any
subsidiary  of  the  Company  of any outstanding  shares  of  the
Company's capital stock;

           (b)   any damage, destruction or loss, whether or  not
covered  by insurance, except for such occurrences that have  not
resulted,  and are not expected to result, in a Material  Adverse
Effect;

           (c)  any waiver by the Company of a valuable right  or
of  a material debt owed to it, except for such waivers that have
not  resulted,  and  are not expected to result,  in  a  Material
Adverse Effect;

          (d)  any material change or amendment to, or any waiver
of  any material rights under, a material contract or arrangement
by  which the Company or any of its assets or properties is bound
or  subject, except for changes, amendments, or waivers that  are
expressly  provided for or disclosed in this  Agreement  or  that
have  not resulted, and are not expected to result, in a Material
Adverse Effect;

           (e)   any  change  by the Company  in  its  accounting
principles,  methods or practices or in the manner it  keeps  its
accounting books and records, except any such change required  by
a change in GAAP; and

<PAGE> 1.8

           (f)   any  other event or condition of any  character,
except for such events and conditions that have not resulted, and
are  not expected to result, either individually or collectively,
in a Material Adverse Effect.

     3.16 Employee Benefits.

           (a)  As used in this Section 3.16, the following terms
have the following meanings:  (1) "Benefit Arrangement" means any
material  benefit  arrangement that is not  an  Employee  Benefit
Plan,  including  (i)  each  material  employment  or  consulting
agreement, (ii) each material arrangement providing for insurance
coverage  or workers' compensation benefits, (iii) each  material
bonus   or   deferred  bonus  arrangement,  (iv)  each   material
arrangement  providing  any termination allowance,  severance  or
similar  benefits, (v) each equity compensation plan,  (vi)  each
deferred  compensation plan and (vii) each material  compensation
policy  and  practice  maintained by  the  Company  covering  the
employees, former employees, officers, former officers, directors
and former directors of the Company, and the beneficiaries of any
of  them;  (2) "Benefit Plan" means an Employee Benefit  Plan  or
Benefit  Arrangement;  (3)"COBRA" means the Consolidated  Omnibus
Budget  Reconciliation Act of 1985, as amended, as set  forth  in
Section  4980B  of the Code and Part 6 of Title I of  ERISA;  (4)
"Employee  Benefit  Plan"  means any employee  benefit  plan,  as
defined   in  Section  3(3)  of  ERISA,  that  is  sponsored   or
contributed  to  by  the Company or any ERISA Affiliate  covering
employees  or  former  employees of the  Company;  (5)  "Employee
Pension Benefit Plan" means any employee pension benefit plan, as
defined  in Section 3(2) of ERISA, that is regulated under  Title
IV  of  ERISA, other than a Multiemployer Plan; (6) "ERISA" means
the  Employee Retirement Income Security Act of 1974, as amended;
(7)  "ERISA Affiliate" of the Company means any other  person  or
entity  that,  together  with  the Company  as  of  the  relevant
measuring date under ERISA, was or is required to be treated as a
single  employer under Section 414 of the Code; (8)"Group  Health
Plan"  means  any  group  health  plan,  as  defined  in  Section
5000(b)(l)  of  the  Code;  (9)  "Multiemployer  Plan"  means   a
multiemployer plan, as defined in Section 3(37) and 4001(a)(3) of
ERISA; and (10) "Prohibited Transaction" means a transaction that
is  prohibited under Section 4975 of the Code or Section  406  of
ERISA  and  not exempt under Section 4975 of the Code or  Section
408 of ERISA, respectively.

            (b)   Neither  the  Company  nor  any  of  its  ERISA
Affiliates sponsors or has sponsored, maintained, contributed to,
or  incurred an obligation to contribute to, any Employee Pension
Benefit  Plan (whether or not terminated).  Neither  the  Company
nor  any  of  its  ERISA Affiliates sponsors  or  has  sponsored,
maintained,   contributed  to,  or  incurred  an  obligation   to
contribute   to,   any  Multiemployer  Plan   (whether   or   not
terminated).

           (c)   No  Employee  Benefit Plan has participated  in,
engaged  in  or  been a party to any Prohibited Transaction,  and
neither  the  Company  nor any of its ERISA  Affiliates  has  had
asserted  against it any claim for any material tax  or  material
penalty  imposed  under ERISA or the Code  with  respect  to  any
Employee   Benefit  Plan  nor,  to  the  best  of  the  Company's
knowledge, is there a basis for any such claim.  To the  best  of
the  Company's knowledge, no officer, director or employee of the
Company has committed a material breach of any

<PAGE> 1.9

responsibility or obligation imposed upon fiduciaries by Title  I
of  ERISA with respect to any Employee Benefit Plan, with respect
to which breach the Company is directly or indirectly liable.

           (d)  Other than routine claims for benefits, there  is
no  material  claim  pending involving any Benefit  Plan  by  any
Person  against such plan or the Company or any ERISA  Affiliate,
nor, to the best of the Company's knowledge, is any such material
claim  threatened.  There is no pending, or to the  best  of  the
Company's knowledge, threatened Proceeding involving any Employee
Benefit  Plan  before  the IRS, the United States  Department  of
Labor or any other governmental authority.

            (e)   No  material  violation  of  any  reporting  or
disclosure  requirement imposed by ERISA or the Code exists  with
respect to any Employee Benefit Plan.

           (f)   Each  Benefit  Plan has been maintained  in  all
material  respects, by its terms and in operation, in  accordance
with  ERISA  (if  applicable), the Code and all other  applicable
federal,  state,  local and foreign laws.  The  Company  and  its
ERISA Affiliates have made full and timely payment of all amounts
required  to  be (i) contributed under the terms of each  Benefit
Plan and such laws, or (ii) required to be paid as expenses under
such  Benefit Plan.  Each Employee Benefit Plan that is  intended
to  be  qualified  under Section 401(a) of the  Code  either  has
received  a favorable determination letter with respect  to  such
qualified status from the IRS or has filed a request for  such  a
determination  letter with the IRS within the remedial  amendment
period  such  that  such determination of qualified  status  will
apply  from  and  after the effective date of any  such  Employee
Benefit Plan.

           (g)  With respect to any Group Health Plans maintained
by  the  Company or its ERISA Affiliates, whether or not for  the
benefit  of  the Company's employees, the Company and  its  ERISA
Affiliates  have  complied  in all  material  respects  with  the
provisions of COBRA.

           (h)   Except  pursuant  to the  provisions  of  COBRA,
neither  the  Company  nor  any  ERISA  Affiliate  maintains  any
Employee Benefit Plan that provides benefits described in Section
3(1)  of  ERISA  for  any former employees or  retirees,  or  the
beneficiaries  of  any  of  them, of the  Company  or  its  ERISA
Affiliates.

     3.17 Tax Matters.

          (a)  All deficiencies asserted or assessments made as a
result of any examinations by the Internal Revenue Service or any
state, local or foreign taxing authority have been fully paid, or
are  fully  reflected  as a liability in  the  Audited  Financial
Statements.   The  Company has filed on a timely  basis  all  Tax
Returns  required  to have been filed by it and  has  paid  on  a
timely basis all Taxes required to be shown thereon as due.   All
such  Tax  Returns are true, complete and correct in all material
respects.   The  provisions for taxes in  the  Audited  Financial
Statements  have  been determined in accordance  with  GAAP.   No
liability  for Taxes has been incurred by the Company  since  the
Balance  Sheet  Date  other than in the ordinary  course  of  its
business.  No director, officer or employee of the Company having
responsibility  for Tax matters has reason to  believe  that  any
Taxing authority has valid grounds to claim or assess any

<PAGE> 1.10

additional  Tax  with respect to the Company  in  excess  of  the
amounts shown in the Audited Financial Statements for the periods
covered  thereby.  As used in this Agreement, (l)  "Taxes"  means
(x) all federal, state, local and other net income, gross income,
gross  receipts, sales use, ad valorem, value added,  intangible,
unitary,  capital  gain, transfer, franchise,  profits,  license,
lease,  service,  service use, withholding,  backup  withholding,
payroll,   employment,  estimated,  excise,   severance,   stamp,
occupation, premium, property, prohibited transactions,  windfall
or   excess  profits,  customs,  duties  or  other  taxes,  fees,
assessments or charges of any kind whatsoever, together with  any
interest  and  any  penalties, additions  to  tax  or  additional
amounts  with respect thereto, (y) any liability for  payment  of
amounts described in clause (x) whether as a result of transferee
liability,  of  being  a  member of an affiliated,  consolidated,
combined  or  unitary group for any period, or otherwise  through
operation of law and (z) any liability for the payment of amounts
described  in clauses (x) or (y) as a result of any tax  sharing,
tax indemnity or tax allocation agreement or any other express or
implied  agreement to indemnify any other person for  Taxes;  and
the term "Tax" means any one of the foregoing Taxes; and (2) "Tax
Returns"  means all returns, reports, forms or other  information
required to be filed with respect to any Tax.

           (b)   With respect to all amounts in respect of  Taxes
imposed upon the Company, or for which the Company is or could be
liable,  whether  to taxing authorities (as, for  example,  under
law) or to other persons or entities (as, for example, under  tax
allocation  agreements), and with respect to all taxable  periods
or  portions of periods ending on or before the Closing Date, all
applicable Tax laws and agreements have been fully complied with,
and all such amounts required to be paid by the Company to taxing
authorities or others have been paid.

           (c)   The  Company has not received  notice  that  the
Internal  Revenue  Service  or any  other  taxing  authority  has
asserted  against  the  Company  any  deficiency  or  claim   for
additional Taxes in connection with any Tax Return, and no issues
have  been  raised  (and  are currently pending)  by  any  taxing
authority in connection with any Tax Return.  The Company has not
received  notice  that  it is or may  be  subject  to  Tax  in  a
jurisdiction in which it has not filed or does not currently file
Tax Returns.

     3.18 Labor Agreements and Actions.

           (a)  No collective bargaining agreement exists that is
binding  on  the  Company,  and no petition  has  been  filed  or
proceedings instituted by an employee or group of employees  with
any  labor  relations board seeking recognition of  a  bargaining
representative.   To  the  best of the  Company's  knowledge,  no
organizational effort is currently being made or threatened by or
on  behalf  of any labor union to organize any employees  of  the
Company.

           (b)   There is no labor strike, dispute, slow down  or
stoppage pending or threatened against or directly affecting  the
Company.  No grievance or arbitration proceeding arising  out  of
or  under any collective bargaining agreement is pending, and  no
claims  therefor exist.  The Company has not received any notice,
and  has  no  knowledge of any threatened labor or  civil  rights
dispute,  controversy  or grievance or  any  other  unfair  labor
practice proceeding or

<PAGE> 1.11

breach  of contact claim or action with respect to claims of,  or
obligations  to,  any  employee or  group  of  employees  of  the
Company.

           (c)   All  individuals  who  are  performing  or  have
performed services for the Company and are or were classified  by
the   Company  as  "independent  contractors"  qualify  for  such
classification under Section 530 of the Revenue Act  of  1978  or
Section 1706 of the Tax Reform Act of 1986, as applicable, except
for  such  instances which would not, in the  aggregate,  have  a
Material Adverse Effect.

      3.19  Real Property Holding Corporation Status.  Since  its
inception the Company has not been a "United States real property
holding corporation", as defined in Section 897(c)(2) of the U.S.
Internal Revenue Code of 1986, as amended, and in Section  1.897-
2(b)   of   the  Treasury  Regulations  issued  thereunder   (the
"Regulations"),  and  the  Company has filed  with  the  Internal
Revenue  Service all statements, if any, with its  United  States
income tax returns which are required under Section 1.897-2(h) of
the Regulations.

      3.20  Full Disclosure.  The information contained  in  this
Agreement and the Disclosure Letter with respect to the business,
operations, assets, results of operations and financial condition
of  the  Company,  and  the  transactions  contemplated  by  this
Agreement,  the  Investor Rights Agreement and the  Warrant,  are
true  and  complete in all material respects and do not  omit  to
state any material fact necessary in order to make the statements
therein,  in  light of the circumstances under  which  they  were
made, not misleading.

4.    REPRESENTATIONS, WARRANTIES AND CERTAIN AGREEMENTS  OF  THE
INVESTOR.   The  Investor hereby represents and warrants  to  the
Company, and agrees that:

      4.l  Authorization.  This Agreement and the Investor Rights
Agreement  have  been duly authorized by all necessary  corporate
action  on  the  part of the Investor.  This  Agreement  and  the
Investor  Rights  Agreement constitute the Investor's  valid  and
legally binding obligations, enforceable in accordance with their
respective  terms,  except as may be limited  by  (a)  applicable
bankruptcy, insolvency, reorganization or other laws  of  general
application   relating  to  or  affecting  the   enforcement   of
creditors'  rights generally and (b) the effect of rules  of  law
governing  the availability of equitable remedies.  The  Investor
has  full  corporate  power  and authority  to  enter  into  this
Agreement and the Investor Rights Agreement

     4.2  Purchase for Own Account.  The Purchased Shares and the
Warrant  are being acquired for investment for the Investors  own
account,  not as a nominee or agent, and not with a view  to  the
public  resale or distribution thereof within the meaning of  the
1933  Act, and the Investor has no present intention of  selling,
granting  any  participation  in, or otherwise  distributing  the
same.   The Investor also represents that it has not been  formed
for  the  specific purpose of acquiring the Purchased Shares  and
the Warrant.

      4.3   Disclosure of Information.  The Investor has received
or  has  had  full  access  to all the information  it  considers
necessary or appropriate to make an informed investment  decision
with  respect  to  the Purchased Shares and  the  Warrant  to  be
purchased by the

<PAGE> 1.12

Investor under this Agreement.  The Investor further has  had  an
opportunity to ask questions and receive answers from the Company
regarding  the  terms  and conditions  of  the  offering  of  the
Purchased  Shares,  the  Warrant and the Warrant  Shares  and  to
obtain additional information necessary to verify any information
furnished  to the investor or to which the Investor  had  access.
The  foregoing, however, does not in any way limit or modify  the
representations and warranties made by the Company in Article 3.

      4.4   Investment Experience.  The Investor understands that
the  purchase  of  the Purchased Shares and the Warrant  involves
substantial risk.  The Investor has experience as an investor  in
securities of companies and acknowledges that it is able to  fend
for  itself, can bear the economic risk of its investment in  the
Purchased  Shares  and  the Warrant and has  such  knowledge  and
experience in financial or business matters that it is capable of
evaluating  the  merits  and  risks of  this  investment  in  the
Purchased Shares and the Warrant and protecting its own interests
in connection with this investment.

      4.5   Accredited  Investor  Status.   The  Investor  is  an
"accredited   investor"  within  the  meaning  of  Regulation   D
promulgated under the 1933 Act.

      4.6   Restricted Securities.  The Investor understands that
the  Purchased  Shares and the Warrant to  be  purchased  by  the
Investor hereunder, and any Warrant Shares to be purchased by the
Investor  upon  exercise  of the Warrant,  are  characterized  as
"restricted securities" under the 1933 Act inasmuch as  they  are
being acquired from the Company in a transaction not involving  a
public  offering  and  that under the  1933  Act  and  applicable
regulations  thereunder such securities  may  be  resold  without
registration   under  the  1933  Act  only  in  certain   limited
circumstances.   The Investor is familiar with Rule  144  of  the
SEC,   as  presently  in  effect,  and  understands  the   resale
limitations  imposed thereby and by the 1933 Act.   The  Investor
understands  that the Company is under no obligation to  register
any  of  the securities sold hereunder except as provided in  the
Investor Rights Agreement.

     4.7  Further Limitations on Disposition.  Without in any way
limiting  the  representations  set  forth  above,  the  Investor
further  agrees not to make any disposition of all or any portion
of the Purchased Shares, the Warrant or the Warrant Shares unless
and until:

           (a)   there is then in effect a registration statement
under  the 1933 Act covering such proposed disposition  and  such
disposition   is  made  in  accordance  with  such   registration
statement; or

           (b)   the  Investor has notified the  Company  of  the
proposed  disposition  and  has  furnished  the  Company  with  a
statement   of   the  circumstances  surrounding   the   proposed
disposition, and the Investor has furnished the Company,  at  the
expense  of  the Investor or its transferee, with an  opinion  of
counsel,  reasonably  satisfactory  to  the  Company,  that  such
disposition  will  not require registration  of  such  securities
under the 1933 Act.

Notwithstanding the provisions of paragraphs (a) and (b) of  this
Section 4.7, no such registration statement or opinion of counsel
will  be  required for any transfer of any Purchased Shares,  the
Warrant,  or any Warrant Shares in compliance with SEC Rule  144,
Rule 144A or Rule 145(d), or

<PAGE> 1.13

any  successor rule of any of the foregoing, or if such  transfer
otherwise is exempt, in the view of the Company's legal  counsel,
from the registration requirements of the 1933 Act.

      4.8  Legends.  Certificates evidencing the Purchased Shares
and  the  Warrant Shares will bear each of the legends set  forth
below and the Warrant will bear the legends set forth in (a)  and
(c) below:

           (a)   THE SECURITIES REPRESENTED HEREBY HAVE NOT  BEEN
REGISTERED  UNDER  THE SECURITIES ACT OF 1933,  AS  AMENDED  (THE
"ACT"),  OR  UNDER THE SECURITIES LAWS OF CERTAIN STATES.   THESE
SECURITIES  ARE  SUBJECT TO RESTRICTIONS ON  TRANSFERABILITY  AND
RESALE  AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS  PERMITTED
UNDER  THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT
TO  REGISTRATION  OR  EXEMPTION THEREFROM.  INVESTORS  SHOULD  BE
AWARE  THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL  RISKS  OF
THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.  THE ISSUER  OF
THESE  SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN  FORM  AND
SUBSTANCE  REASONABLY SATISFACTORY TO THE ISSUER  TO  THE  EFFECT
THAT  ANY  PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH  THE
ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

           (b)   THE  SHARES  EVIDENCED BY THIS  CERTIFICATE  ARE
SUBJECT  TO CERTAIN RESTRICTIONS SPECIFIED IN A CERTAIN  INVESTOR
RIGHTS  AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER  OF
SUCH  SHARES  DATED  AS OF MARCH 18, 1997, A  COPY  OF  WHICH  IS
AVAILABLE FOR EXAMINATION AT THE ISSUER'S PRINCIPAL OFFICE.

           (c)   Any  Legends  required by any  applicable  state
securities laws.

The Legend set forth in Section 4.8(a) hereof will be removed  by
the  Company from any certificate evidencing Purchased Shares  or
the Warrant Shares upon delivery to the Company of an opinion  by
counsel,   reasonably  satisfactory  to  the  Company,   that   a
registration  statement under the 1933 Act is  at  that  time  in
effect  with  respect  to  the legended  security  or  that  such
security  can  be  transferred in a public sale  without  such  a
registration  statement being in effect and  that  such  transfer
will not jeopardize the exemption or exemptions from registration
pursuant  to  which the Company issued the Purchased Shares,  the
Warrant or the Warrant Shares.

5.    CONDITIONS TO THE INVESTOR'S OBLIGATIONS AT  CLOSING.   The
obligations  of  the Investor under Sections  l  and  2  of  this
Agreement are subject to the fulfillment or waiver, on or  before
the  Closing  (defined in Section 2.l), of each of the  following
conditions:

      5.1   Representations and Warranties  True.   Each  of  the
representations  and  warranties  of  the  Company  contained  in
Section  3 will be true and correct on and as of the date  hereof
and on and as of the date of the Closing, except as set forth  in
the  Disclosure  Letter,  with the same  effect  as  though  such
representations and warranties had been made as of the Closing.

<PAGE> 1.14

      5.2   Performance.   The Company will  have  performed  and
complied   with   all  agreements,  obligations  and   conditions
contained in this Agreement that are required to be performed  or
complied  with  by  it  on or before the Closing  and  will  have
obtained all approvals, consents and qualifications necessary  to
complete the purchase and sale described herein.

       5.3    Compliance  Certificate.   The  Company  will  have
delivered to the Investor at the Closing a certificate signed  on
its  behalf  by  its Chief Executive Officer or  Chief  Financial
Officer certifying that the conditions specified in Sections  5.1
and 5.2 hereof have been fulfilled.

      5.4   Securities  Exemptions.  The offer and  sale  of  the
Purchased Shares and the Warrant to the Investor pursuant to this
Agreement  will  be exempt from the registration requirements  of
the   1933   Act   and  the  registration  and/or   qualification
requirements of all applicable state securities laws.

      5.5   Proceedings and Documents.  All corporate  and  other
proceedings  in connection with the transactions contemplated  at
the Closing and all documents incident thereto will be reasonably
satisfactory  in  form  and substance to the  Investor,  and  the
Investor  will  have received all such counterpart originals  and
certified  or other copies of such documents as it may reasonably
request.   Such documents shall include (but not be  limited  to)
the following:

           (a)   Certified Charter Documents.  A copy of (i)  the
Certificate of Incorporation certified as of a recent date by the
Secretary  of  State of Delaware as a complete and  correct  copy
thereof,  and (ii) the Bylaws of the Company (as amended  through
the  date  of  the  Closing) certified by the  Secretary  of  the
Company as true and correct copies thereof as of the Closing.

           (b)   Board  Resolutions.  A copy,  certified  by  the
Secretary  of  the Company, of the resolutions of  the  Board  of
Directors  of  the  Company providing for the  approval  of  this
Agreement  and the Investor Rights Agreement and the issuance  of
the  Purchased  Shares  and the Warrant  and  the  other  matters
contemplated hereby.

      5.6   Opinion of Company Counsel.  The Investor  will  have
received  an opinion on behalf of the Company, dated  as  of  the
date  of  the  Closing,  from Loeb & Loeb  L.L.P.,  in  form  and
substance reasonably satisfactory to the Investor.

      5.7   Warrant and Investor Rights Agreement.   The  Company
will have issued the Warrant and will have executed and delivered
the  Investor Rights Agreement substantially in the form attached
to this Agreement as Exhibit B (the "Investor Rights Agreement").

      5.8   No Material Adverse Effect.  Between the date  hereof
and  the  Closing,  there shall not have  occurred  any  Material
Adverse Effect.

6.    CONDITIONS  TO THE COMPANY'S OBLIGATIONS AT  CLOSING.   The
obligations  of the Company to the Investor under this  Agreement
are subject to the fulfillment or waiver on or before the Closing
(defined in Section 2.1), of each of the following conditions:

<PAGE> 1.15

        6.1    Representations   and   Warranties   True.     The
representations  and  warranties of  the  Investor  contained  in
Section  4 will be true and correct on and as of the date  hereof
and on and as of the date of the Closing with the same effect  as
though  such representations and warranties had been made  as  of
the Closing.

      6.2   Payment  of Purchase Price.  The Investor  will  have
delivered to the Company the full purchase price of the Purchased
Shares as specified in Section 1.2.

      6.3   Securities  Exemptions.  The offer and  sale  of  the
Purchased Shares and the Warrant to the Investor pursuant to this
Agreement  will  be exempt from the registration requirements  of
the   1933   Act   and  the  registration  and/or   qualification
requirements of all applicable state securities laws.

      6.4   Proceedings and Documents.  All corporate  and  other
proceedings  in connection with the transactions contemplated  at
the Closing and all documents incident thereto will be reasonably
satisfactory  in  form and substance to the Company  and  to  the
Company's  legal counsel, and the Company will have received  all
such  counterpart originals and certified or other copies of such
documents as it may reasonably request.

      6.5   Investor  Rights Agreement.  The Investor  will  have
executed and delivered the Investor Rights Agreement.

7.   INDEMNIFICATION.

     7.1  Agreement to Indemnify.

           (a)   Company Indemnity.  The Investor, its Affiliates
and   Associates,   and  each  officer,  director,   shareholder,
employer,  representative  and agent  of  any  of  the  foregoing
(collectively,  the  "Investor  Indemnitees")   shall   each   be
indemnified  and held harmless to the extent set  forth  in  this
Section 7 by the Company with respect to any and all Damages  (as
defined below) incurred by any Investor Indemnitee as a proximate
result  of any inaccuracy or misrepresentation in, or breach  of,
any  representation, warranty, covenant or agreement made by  the
Company in this Agreement, the Investor Rights Agreement  or  the
Warrant (including any Exhibits and Schedules hereto).

           (b)   Investor Indemnity.  The Company, its respective
Affiliates   and   Associates,  and   each   officer,   director,
shareholder,  employer, representative and agent of  any  of  the
foregoing (collectively, the "Company Indemnitees") shall each be
indemnified  and held harmless to the extent set  forth  in  this
Section  7,  by the Investor, in respect of any and  all  Damages
incurred  by any Company Indemnitee as a result of any inaccuracy
or  misrepresentation  in,  or  breach  of,  any  representation,
warranty,  covenant  or agreement made by the  Investor  in  this
Agreement or the Investor Rights Agreement.

           (c)   Equitable  Relief.  Nothing set  forth  in  this
Section  7  shall  be  deemed to prohibit or limit  any  Investor
Indemnitee's or Company Indemnitee's right at any time

<PAGE> 1.16

before, on or after the Closing Date, to seek injunctive or other
equitable  relief  for the failure of any Indemnifying  Party  to
perform  or  comply  with  any covenant  or  agreement  contained
herein.

      7.2   Survival.  All representations and warranties of  the
Investor  and  the Company contained herein or  in  the  Investor
Rights  Agreement or the Warrant, and all claims of any  Investor
Indemnitee or Company Indemnitee in respect of any inaccuracy  or
misrepresentation in or breach thereof, shall survive the Closing
until  the later of (i) the date of termination of the  Right  of
Participation under the Investor Rights Agreement, and  (ii)  the
third  anniversary of the date of this Agreement,  regardless  of
whether   the   applicable  statute  of  limitations,   including
extensions thereof, may expire.  All covenants and agreements  of
the  Investor and the Company contained herein or in the Investor
Rights  Agreement  or the Warrant shall survive  the  Closing  in
perpetuity  (except to the extent any such covenant or  agreement
shall   expire  by  its  terms).   All  claims  of  any  Investor
Indemnitee or Company Indemnitee in respect of any breach of such
covenants  or  agreements shall survive  the  Closing  until  the
expiration  of  two  years  following the  non-breaching  party's
obtaining actual knowledge of such breach.

     7.3  Claims for Indemnification.  If any Investor Indemnitee
or  Company Indemnitee (an "Indemnitee") shall believe that  such
Indemnitee  is  entitled  to  indemnification  pursuant  to  this
Section  7 in respect of any Damages, such Indemnitee shall  give
the appropriate Indemnifying Party (which for purposes hereof, in
the case of an Investor Indemnitee, means the Company, and in the
case  of a Company Indemnitee, means the Investor) prompt written
notice  thereof.  Any such notice shall set forth  in  reasonable
detail and to the extent then known the basis for such claim  for
indemnification.  The failure of such Indemnitee to  give  notice
of  any  claim  for indemnification promptly shall not  adversely
affect  such Indemnitee's right to indemnity hereunder except  to
the  extent that such failure adversely affects the right of  the
Indemnifying  Party  to  assert any reasonable  defense  to  such
claim.  Each such claim for indemnity shall expressly state  that
the  Indemnifying Party shall have only the twenty (20)  business
day  period referred to in the next sentence to dispute  or  deny
such  claim.   The  Indemnifying Party  shall  have  twenty  (20)
business days following its receipt of such notice either (a)  to
acquiesce in such claim by giving such Indemnitee written  notice
of such acquiescence or (b) to object to the claim by giving such
Indemnitee  written  notice  of the objection.   If  Indemnifying
Party  does  not object thereto within such twenty (20)  business
day  period,  such Indemnitee shall be entitled to be indemnified
for  all  Damages  reasonably and proximately  incurred  by  such
Indemnitee  in respect of such claim.  If the Indemnifying  Party
objects  to  such claim in a timely manner, the senior management
of  the Company and the Investor shall meet to attempt to resolve
such  dispute.  If the dispute cannot be resolved by  the  senior
management  either  party may make a written  demand  for  formal
dispute  resolution and specify therein the scope of the dispute.
Within  thirty days after such written notification, the  parties
agree to meet for one day with an impartial mediator and consider
dispute  resolution alternatives other than  litigation.   If  an
alternative  method  of dispute resolution  is  not  agreed  upon
within thirty days after the one day mediation, either party  may
begin  litigation proceedings.  Nothing in this section shall  be
deemed to require arbitration.

      7.4   Defense of Claims.  In connection with any claim that
may give rise to indemnity under this Section 7 resulting from or
arising out of any claim or Proceeding against

<PAGE> 1.17

an  Indemnitee by a person or entity that is not a party  hereto,
the  Indemnifying Party may but shall not be obligated to (unless
such  Indemnitee elects not to seek indemnity hereunder for  such
claim),  upon  written notice to the relevant Indemnitee,  assume
the  defense  of any such claim or proceeding if the Indemnifying
Party  with  respect to such claim or Proceeding acknowledges  to
the  Indemnitee  the  Indemnitee's right  to  indemnity  pursuant
hereto to the extent provided herein (as such claim may have been
modified  through written agreement of the parties or arbitration
hereunder)   and  provides  assurances,  satisfactory   to   such
Indemnitee, that the Indemnifying Party will be financially  able
to satisfy such claim to the extent provided herein if such claim
or  Proceeding  is  decided adversely;  provided,  however,  that
nothing  set  forth  herein  shall  be  deemed  to  require   the
Indemnifying Party to waive any crossclaims or counterclaims  the
Indemnifying  Party  may have against the Indemnified  Party  for
damages.   The  Indemnified Party shall  be  entitled  to  retain
separate  counsel,  reasonably  acceptable  to  the  Indemnifying
Party,  if  the  Indemnified Counsel shall  determine,  upon  the
written  advice of counsel, that an actual or potential  conflict
of  interest  exists  between  the  Indemnifying  Party  and  the
Indemnified  Party  in  connection  with  such  Proceeding.   The
Indemnifying Party shall be obligated to pay the reasonable  fees
and   expenses  of  such  separate  counsel  to  the  extent  the
Indemnified   Party  is  entitled  to  indemnification   by   the
Indemnifying Party with respect to such claim or Proceeding under
this  Section 7.4.  If the Indemnifying Party assumes the defense
of  any  such  claim or Proceeding, the Indemnifying Party  shall
select  counsel  reasonably  acceptable  to  such  Indemnitee  to
conduct  the defense of such claim or Proceeding, shall take  all
steps necessary in the defense or settlement thereof and shall at
all  times diligently and promptly pursue the resolution thereof.
If  the Indemnifying Party shall have assumed the defense of  any
claim  or  Proceeding in accordance with this  Section  7.4,  the
Indemnifying Party shall be authorized to consent to a settlement
of, or the entry of any judgment arising from, any such claim  or
Proceeding,  with  the prior written consent of such  Indemnitee,
not  to  be  unreasonably withheld; provided, however,  that  the
Indemnifying  Party  shall pay or cause to be  paid  all  amounts
arising out of such settlement or judgment concurrently with  the
effectiveness  thereof; provided, further, that the  Indemnifying
Party  shall not be authorized to encumber any of the  assets  of
any Indemnitee or to agree to any restriction that would apply to
any  Indemnitee  or  to  its conduct of business;  and  provided,
further,  that  a  condition to any such settlement  shall  be  a
complete   release  of  such  Indemnitee  and   its   Affiliates,
directors,  officers, employees and agents with respect  to  such
claim,    including   any   reasonably   foreseeable   collateral
consequences  thereof.   Such Indemnitee  shall  be  entitled  to
participate in (but not control) the defense of any such  action,
with  its  own  counsel and at its own expense.  Each  Indemnitee
shall,  and  shall  cause  each  of  its  Affiliates,  directors,
officers,  employees  and  agents to, cooperate  fully  with  the
Indemnifying  Party  in the defense of any  claim  or  Proceeding
being defended by the Indemnifying Party pursuant to this Section
7.4.   If  the Indemnifying Party does not assume the defense  of
any  claim  or Proceeding resulting therefrom in accordance  with
the terms of this Section 7.4, such Indemnitee may defend against
such   claim  or  Proceeding  in  such  manner  as  it  may  deem
appropriate,  including settling such claim or  proceeding  after
giving  notice  of the same to the Indemnifying  Party,  on  such
terms   as  such  Indemnitee  may  deem  appropriate.    If   any
Indemnifying  Party seeks to question the manner  in  which  such
Indemnitee defended such claim or Proceeding or the amount of  or
nature of any such settlement, such Indemnifying Party shall have
the  burden to prove by a preponderance of the evidence that such
Indemnitee  did  not  defend  such  claim  or  Proceeding  in   a
reasonably prudent manner.

<PAGE> 1.18

      7.5   Certain Definitions.  As used in this Section 7,  (a)
"Affiliate"  means,  with respect to any person  or  entity,  any
person  or  entity directly or indirectly controlling, controlled
by  or  under direct or indirect common control with  such  other
person or entity; (b) "Associate" means, when used to indicate  a
relationship with any person or entity, (l) any other  person  or
entity  of  which  such  first person or entity  is  an  officer,
director or partner or is, directly or indirectly, the beneficial
owner  of  ten  percent  (10%) or more of  any  class  of  equity
securities,  membership interests or other  comparable  ownership
interests issued by such other person or entity, (2) any trust or
other  estate  in  which such first person or entity  has  a  ten
percent  (10%)  or more beneficial interest or as to  which  such
first  person  or  entity  serves as  trustee  or  in  a  similar
fiduciary capacity, and (3) any relative or spouse of such  first
person  or  entity who has the same home as such first person  or
entity  or  who is a director or officer of such first person  or
entity;  (c)  "Damages"  means all demands,  claims,  actions  or
causes  of action, assessments, losses, damages, costs, expenses,
liabilities, judgments, awards, fines, response costs, sanctions,
taxes,   penalties,  charges  and  amounts  paid  in  settlement,
including (1) interest on cash disbursements in respect of any of
the  foregoing at the prime rate of Bank of America, NT & SA,  as
in  effect from time to time, compounded quarterly, from the date
each  such  cash  disbursement is made until the date  the  party
incurring  such cash disbursement shall have been indemnified  in
respect thereof, and (2) reasonable out-of-pocket costs, fees and
expenses  (including  reasonable  costs,  fees  and  expenses  of
attorneys,  accountants and other agents  of,  or  other  parties
retained by, such party), and (d) "Proceeding" means any  action,
suit, hearing, arbitration, audit, proceeding (public or private)
or  investigation that is brought or initiated by or against  any
federal,  state, local or foreign governmental authority  or  any
other person or entity.

8.   MISCELLANEOUS.

      8.1   Successors and Assigns.  The terms and conditions  of
this  Agreement will inure to the benefit of and be binding  upon
the respective successors and assigns of the parties.

      8.2  Governing Law.  This Agreement will be governed by and
construed  under  the  internal laws of the  State  of  Delaware,
without reference to principles of conflict of laws or choice  of
laws.

     8.3  Counterparts.  This Agreement may be executed in two or
more counterparts, each of which will be deemed an original,  but
all   of  which  together  will  constitute  one  and  the   same
instrument.

      8.4   Headings.   The headings and captions  used  in  this
Agreement  are  used  for convenience only  and  are  not  to  be
considered  in  construing or interpreting this  Agreement.   All
references  in  this Agreement to sections, paragraphs,  exhibits
and  schedules will, unless otherwise provided, refer to sections
and paragraphs hereof and exhibits and schedules attached hereto,
all  of  which exhibits and schedules are incorporated herein  by
this reference.

      8.5   Notices.  Any notice required or permitted under this
Agreement  will  be  given in writing, shall  be  effective  when
received,  and  shall  in  any  event  be  deemed  received   and
effectively  given  upon personal delivery to  the  party  to  be
notified or three (3) business days after deposit with the United
States  Post  Office,  by registered or certified  mail,  postage
prepaid,

<PAGE> 1.19

or   one  (1)  business  day  after  deposit  with  a  nationally
recognized  courier service such as Fedex for next  business  day
delivery  under  circumstances in which such  service  guarantees
next  business  day  delivery, or  one  (1)  business  day  after
facsimile  with  copy delivered by registered or certified  mail,
postage prepaid and addressed to the party to be notified at  the
address indicated for such party on the signature page hereof  or
at  such  other  address  as  the Investor  or  the  Company  may
designate by giving at least ten (10) days advance written notice
pursuant to this Section 8.5.

      8.6   No  Finder's  Fees.  Each party  represents  that  it
neither is nor will be obligated for any finder's or broker's fee
or  commission in connection with this transaction.  The Investor
will  indemnify and hold harmless the Company from any  liability
for any commission or compensation in the nature of a finders' or
broker's  fee  for  which the Investor or any  of  its  officers,
partners,   employees  or  consultants,  or  representatives   is
responsible.   The Company will indemnify and hold  harmless  the
Investor from any liability for any commission or compensation in
the nature of a finder's or broker's fee for which the Company or
any  of its officers, employees or consultants or representatives
is responsible.

      8.7  Amendments and Waivers.  This Agreement may be amended
and  the  observance of any term of this Agreement may be  waived
(either  generally  or  in  a  particular  instance  and   either
retroactively or prospectively), only with the written consent of
the  Company  and the holders of Purchased Shares and/or  Warrant
Shares  representing at least a majority of the  total  aggregate
number  of  Purchased Shares and Warrant Shares then  outstanding
(excluding  any of such shares that have been sold to the  public
pursuant to SEC Rule 144 or otherwise).  Any amendment or  waiver
effected in accordance with this Section 8.7 will be binding upon
the  Investor,  the Company and their respective  successors  and
assigns.

      8.8   Severability.  If any provision of this Agreement  is
held  to  be  unenforceable under applicable law, such  provision
will  be  excluded  from this Agreement and the  balance  of  the
Agreement  will  be  interpreted as if  such  provision  were  so
excluded and will be enforceable in accordance with its terms.

      8.9   Entire Agreement.  This Agreement, together with  all
Exhibits  and schedules hereto, constitutes the entire  agreement
and  understanding  of the parties with respect  to  the  subject
matter  hereof  and  supersedes any and all  prior  negotiations,
correspondence, agreements, understandings duties or  obligations
between the parties with respect to the subject matter hereof.

      8.10  Further Assurances.  From and after the date of  this
Agreement  upon the request of the Investor or the  Company,  the
Company   and   the  Investor  will  execute  and  deliver   such
instruments,  documents or other writings as  may  be  reasonably
necessary or desirable to confirm and carry out and to effectuate
fully the intent and purposes of this Agreement.

      8.11  Meaning of Include and Including.  Whenever  in  this
Agreement the word "include" or "including" is used, it shall  be
deemed  to  mean  "include,  without limitation"  or  "including,
without  limitation,"  as  the case  may  be,  and  the  language
following  "include" or "including" shall not be  deemed  to  set
forth an exhaustive list.

<PAGE> 1.20

     8.12 Fees, Costs and Expenses.  All fees, costs and expenses
(including attorneys' fees and expenses) incurred by either party
hereto  in  connection  with  the  preparation,  negotiation  and
execution  of  this Agreement, the Investor Rights Agreement  and
the Warrant and the consummation of the transactions contemplated
hereby  and  thereby  (including the costs  associated  with  any
filings with, or compliance with any of the requirements of,  any
governmental  authorities),  shall  be  the  sole  and  exclusive
responsibility of such party.

[The remainder of this page is intentionally left blank.]

<PAGE> 1.21

IN  WITNESS  WHEREOF,  the  parties  hereto  have  executed  this
Agreement as of the date first above written.

STANDARD MICROSYSTEMS               INTEL CORPORATION
CORPORATION
                                    
By:  _______________________        By:  _______________________
                                    
Name:  _____________________        Name:  _____________________
                                    
Title:  ____________________        Title:  ____________________
                                    
Date signed:  ______________        Date signed:  ______________
                                    
Address:  __________________        Address:  __________________
          __________________                  __________________
          __________________                  __________________
                                    
Telephone No.:  ____________        Telephone No.:  ____________
                                    
Facsimile No.:  ____________        Facsimile No.:  ____________


[Signature Page to Common Stock and Warrant Purchase Agreement]

<PAGE> 1.22

           COMMON STOCK AND WARRANT PURCHASE AGREEMENT
                                
                        LIST OF EXHIBITS
                                
Exhibit A  -  Form of Warrant
              
Exhibit B  -  Form of Investor Rights Agreement
              






                            EXHIBIT 2
                                
                                
                   WARRANT TO PURCHASE SHARES
                         OF COMMON STOCK
                               OF
                STANDARD MICROSYSTEMS CORPORATION
<PAGE> 2.1
                            EXHIBIT A
                                
THE  SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER
THE  SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER THE
SECURITIES LAWS OF CERTAIN STATES.  THESE SECURITIES ARE  SUBJECT
TO  RESTRICTIONS ON TRANSFERABILITY AND RESALE  AND  MAY  NOT  BE
TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT  AND  THE
APPLICABLE  STATE  SECURITIES LAWS, PURSUANT TO  REGISTRATION  OR
EXEMPTION THEREFROM.  INVESTORS SHOULD BE AWARE THAT THEY MAY  BE
REQUIRED  TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT  FOR  AN
INDEFINITE  PERIOD OF TIME.  THE ISSUER OF THESE  SECURITIES  MAY
REQUIRE  AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY
TO  THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE
IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES
LAWS.

                                      Void after 5:00 p.m.,
                                      Pacific Time
                                      on March 18, 2000
                                      
                                
           WARRANT TO PURCHASE SHARES OF COMMON STOCK
                               OF
                STANDARD MICROSYSTEMS CORPORATION


          Initial Number of Shares:     1,542,606
          Date of Grant:                March 18, 1997
          Expiration Date:              March 18, 2000
                                        
THIS  CERTIFIES THAT, for value received pursuant to that certain
Common Stock and Warrant Purchase Agreement dated as of March 18,
1997  (the "Purchase Agreement), Intel Corporation and any person
to  whom  the  interest  in this Warrant is lawfully  transferred
pursuant  to  the  terms  and conditions set  forth  herein  (the
original  holder  hereof  and such transferees  are  referred  to
hereinafter as the "Holder") is entitled to purchase, at any time
and  from  time to time after the date hereof, up  to  the  above
number  (as adjusted pursuant to Section 2 hereof) of fully  paid
and  nonassessable shares of the Common Stock (the  "Shares")  of
Standard  Microsystems Corporation, a Delaware  corporation  (the
"Company"),  at the applicable Per Share Purchase  Price  as  set
forth  in Section 1.1 hereof, subject to the provisions and  upon
the terms and conditions set forth herein.

This Warrant is subject to the following terms and conditions:

1.   EXERCISE.

      1.1   Per  Share  Purchase Price.  The "Per Share  Purchase
Price"  at  which this Warrant may be exercised shall be  as  set
forth  in  the following table, subject to adjustment as provided
in Section 2 hereof:

<PAGE> 2.2

             Date of Exercise                Price
             ----------------                -----
From March 18, 1997 through March 18, 1998  $10.45
                                            
From March 18, 1998 through March 18, 1999  $11.40
                                            
From March 18, 1999 through March 18, 2000  $12.35
                                            
Notwithstanding  the  foregoing  and  subject  to  adjustment  as
provided  in  Section 2 hereof, the Per Share Purchase  Price  at
which  309,809 Shares of this Warrant may be exercised  shall  be
not  less  than the book value per share as of February 28,  1997
(determined  from the Company's balance sheet as of February  28,
1997 as contained in the Company's Annual Report on Form 10-K for
the fiscal year ended February 28, 1997).

      1.2  Expiration.  This Warrant shall expire and be canceled
in  its entirety on the Expiration Date set forth above and  must
be  exercised,  if  at  all,  on or before  the  Expiration  Date
(subject only to the provisions of Section 1.6 below).

     1.3  Exercise.

          (a)  The purchase right represented by this Warrant may
be  exercised by the Holder, in whole or in part, for up  to  the
total number of shares then exercisable, by the surrender of this
Warrant  (with  the Common Stock Warrant Notice of Exercise  form
attached hereto as Annex I duly executed) at the principal office
of  the  Company and by the payment to the Company  in  cash  (by
certified  check or wire transfer) or by surrender of  shares  of
Common  Stock  of  the Company valued at their Market  Price  (as
defined below) on the date of surrender, or a combination of  the
foregoing,  in  an  amount equal to the then applicable  Purchase
Price  Per  Share multiplied by the number of Shares  then  being
purchased.

           (b)  In lieu of exercising this Warrant by payment  of
cash,  when  permitted  by  law and applicable  regulations,  the
Holder  may  pay  such exercise price through a "same  day  sale"
commitment from the Holder and a broker-dealer that is  a  member
of  the  National  Association of Securities  Dealers  (an  "NASD
Dealer")  whereby the Holder irrevocably elects to  exercise  the
Warrant and to sell a portion of the Shares so purchased  to  pay
for  the  exercise price and whereby the NASD Dealer  irrevocably
commits upon receipt of such Shares to forward the exercise price
directly to the Company.

           (c)  In lieu of exercising this Warrant by payment  of
cash  or by payment through a same day sale, the Holder may elect
to  receive, without the payment by the Holder of any  additional
consideration,  a number of shares (rounded down to  the  nearest
whole  share) equal to the value of this Warrant or  any  portion
hereof  by the surrender of this Warrant or such portion  to  the
Company  (the  "Net  Exercise"),  with  the  net  issue  election
initialed in the Common Stock Warrant Notice of Exercise  annexed
hereto duly executed, at the office of the

<PAGE> 2.3

Company.   Thereupon the Company will issue to  the  Holder  such
number  of  shares of Common Stock of the Company as is  computed
using the following formula.

                           X = Y (A-B)
                               -------
                                   A

where X =  the  number of shares of Common Stock to be issued  to
           the  Holder  upon  the Net Exercise pursuant  to  this
           Section 1.3;
           
Y =        the  number of Shares exercised under this Warrant for
           which the net issue election is made pursuant to  this
           Section  1.3  (upon such Net Exercise, the  number  of
           shares  subject to further exercise under this Warrant
           shall be reduced by this number);
           
A =        the  Market Price (as defined below) of one  share  of
           the  Company's Common Stock on the date the net  issue
           election is made pursuant to this Section 1.3; and
           
B =        the  Per  Share  Purchase Price in effect  under  this
           Warrant  on  the date the net issue election  is  made
           pursuant to this Section 1.3.
           
For  purposes of this Section 1.3, "Market Price" means, as to  a
share of Common Stock, the average of the closing prices of sales
on  all  domestic securities exchanges on which the Common  Stock
may at the time be listed, or, if there have been no sales on any
such  exchange  on any day, the average of the  highest  bid  and
lowest asked prices on all such exchanges at the end of such day,
or,  if on any day the Common Stock is not so listed, the average
of  the  representative bid and asked prices quoted in the Nasdaq
National Market as of 4:00 P.M., New York time, on such day,  or,
if  on  any  day  the Common Stock is not quoted  in  the  Nasdaq
National Market, the average of the highest bid and lowest  asked
prices  on  such day in the domestic over-the-counter  market  as
reported by the National Quotation Bureau, Incorporated,  or  any
similar successor organization, in each such case averaged over a
period of thirty (30) Trading Days immediately preceding the date
the net issue election or other exercise is made pursuant to this
Section  1.3;  provided, however, that if  the  Common  Stock  is
listed  on  any  domestic securities exchange the  term  "Trading
Days"  as used in this sentence means days on which such exchange
is  open  for  trading.  If at any time the Common Stock  is  not
listed  on  any  domestic securities exchange or  quoted  in  the
Nasdaq  National Market or the domestic over-the counter  market,
the  "Market  Price"  shall be the fair value thereof  determined
jointly by the Company and the Holder; provided, however, that if
such  parties  are unable to reach agreement within fifteen  (15)
business  days  following written notice from the Holder  to  the
Company  setting forth the Holder's determination  of  such  fair
value,  such  fair  value  shall be determined  by  an  appraiser
jointly   selected   by  the  Company  and   the   Holder.    The
determination of such appraiser shall be final and binding on the
Company  and  the  Holder,  and the fees  and  expenses  of  such
appraiser shall be paid by the Company

     1.4  Limitations on Exercise.  The exercise of this Warrant,
and the issuance of the Shares will be subject to and conditioned
upon compliance by the Company and the Holder with all applicable
state  and  federal laws and regulations and with all  applicable
requirements of

<PAGE> 2.4

any  stock  exchange or automated quotation system on  which  the
Company's  common stock may be listed or quoted at  the  time  of
such  issuance or transfer.  The Company shall, at its sole  cost
and expense, use its reasonable best efforts to make all filings,
notices  and  applications  required by  the  Company  (excluding
filings,  notices and applications required by the  Holder),  and
take  all other actions necessary to permit the exercise of  this
Warrant  by  the  Holder and the issuance of the  Shares  to  the
Holder,  and  the  Holder  shall cooperate  with  all  reasonable
requests  of  the Company in connection therewith.  This  Warrant
may not be exercised as to fewer than 50,000 Shares unless it  is
exercised  as  to  all  Shares as to which the  Warrant  is  then
exercisable.

      1.5  Issuance of New Warrant.  In the event of any exercise
of  the  purchase right represented by this Warrant, certificates
for  the  Shares  so purchased will be delivered  to  the  Holder
within four (4) business days after receipt of such payment  and,
unless  this Warrant has been fully exercised or has  expired,  a
new  Warrant representing the portion of the Shares, if any, with
respect  to which this Warrant will not then have been  exercised
will also be issued to the Holder within a reasonable time.

     1.6  Hart Scott-Rodino Compliance.

           (a)  The Company hereby acknowledges that the exercise
of  this  Warrant  by Holder may subject the Company  and/or  the
Holder  to  the  filing  requirements of  the  Hart-Scott  Rodino
Antitrust Improvements Act of 1976 (the "HSR Act") and  that  the
Holder may be prevented from closing the exercise of this Warrant
until  the expiration or early termination of all waiting periods
imposed by, and compliance with all other requirements under, the
HSR  Act  ("HSR  Requirements").  If on or before the  Expiration
Date, the Holder (i) has sent the Common Stock Warrant Notice  of
Exercise to the Company, (ii) has irrevocably elected to exercise
this  Warrant for the number of Shares specified in  such  notice
subject  only to compliance with the HSR Requirements, and  (iii)
the  Holder  has not been able to complete the exercise  of  this
Warrant  prior to the Expiration Date solely because of  the  HSR
Requirements, then, for so long as the Holder actively  continues
in  its  effort to comply with the HSR Requirements,  the  Holder
shall  be  entitled  to complete the process of  exercising  this
Warrant  for  such  number  of  Shares  in  accordance  with  the
procedures  contained  herein  notwithstanding  the   fact   that
completion of the exercise of this Warrant would take place after
the  Expiration Date.  If an exercise by Holder is subject to HSR
Requirements, the amount payable upon such exercise shall be paid
to  the  Company  within five (5) business days of  the  Holder's
receiving  written  notice  the expiration  or  notice  of  early
termination of, or compliance with, all HSR Requirements.

            (b)   The  Company  and  the  Holder  shall  use  all
reasonable efforts to comply with the HSR Requirements; provided,
however,  that neither the Company nor the Holder shall be  under
any  obligation to comply with any request or requirement imposed
by  the  Federal Trade Commission (the "FTC"), the Department  of
Justice   ("DofJ")  or  any  other  governmental   authority   in
connection with their compliance with the HSR Requirements if the
Company  or the Holder reasonably determines that such compliance
is  unduly  burdensome.  Without limiting the generality  of  the
foregoing, neither the Company nor the Holder shall be  obligated
to  comply with any request by, or requirement of, the  FTC,  the
DofJ  or  any  other  governmental  authority,  that  such  party
determines is unduly burdensome:  (i) to disclose

<PAGE> 2.5

information  the  Company or the Holder,  as  the  case  may  be,
desires  to keep confidential; (ii) to dispose or any  assets  or
operations; or (iii) to comply with any restriction on the manner
in  which they conduct their respective operations.  In the event
that the Company fails to comply with any of the HSR Requirements
pursuant  to  the  immediately preceding sentence,  it  shall  be
obligated  to  pay to the Holder within sixty (60) business  days
following written election from the Holder an amount equal to the
difference between:  (1) the Market Price as of the date  of  the
Common Stock Warrant Notice of Exercise, multiplied by the number
of  Shares  to which such notice relates; and (2) the  Per  Share
Purchase Price, multiplied by the number of such Shares.

2.   ADJUSTMENT OF NUMBER OF SHARES AND PER SHARE PURCHASE PRICE.
The  number  of  Shares  purchasable upon the  exercise  of  this
Warrant,  and  the Per Share Purchase Price, will be  subject  to
adjustment from time to time as provided in this Section 2:

      2.1   Subdivision or Combination of Common Stock.   If  the
Company  at  any  time  subdivides (by  any  stock  split,  stock
dividend,  recapitalization or otherwise) its outstanding  shares
of  Common  Stock into a greater number of shares, the Per  Share
Purchase  Price  in effect immediately prior to such  subdivision
shall  be  proportionately reduced and the number  of  shares  of
Common  Stock obtainable upon exercise of this Warrant  shall  be
proportionately increased.  If the Company at any  time  combines
(by  reverse stock split or otherwise) its outstanding shares  of
Common  Stock  into  a smaller number of shares,  the  Per  Share
Purchase  Price  in effect immediately prior to such  combination
shall  be  proportionately increased and the number of shares  of
Common  Stock obtainable upon exercise of this Warrant  shall  be
proportionately decreased.

     2.2  Stock Dividends.  If the Company at any time while this
Warrant  remains  outstanding  and  unexpired  pays  a  dividend,
without  receipt  of consideration therefor, to  the  holders  of
Common  Stock payable in shares of Common Stock, Preferred Stock,
other  capital  stock  or other securities  convertible  into  or
exchangeable  for Common Stock, Preferred Stock or other  capital
stock  ("Convertible Securities"), or options to purchase  Common
Stock,  Preferred  Stock,  other  capital  stock  or  Convertible
Securities ("Options"), other than any event for which adjustment
is  made  pursuant to Section 2.1 hereof, the Holder shall,  upon
exercise  of this Warrant be entitled to receive, in addition  to
the  number of Shares receivable thereupon, the amount of  Common
Stock,   Preferred   Stock,  other  capital  stock,   Convertible
Securities or Options that such Holder would have received had it
been  Holder  of record of such Shares as of the  date  on  which
holders  of  Common Stock received or became entitled to  receive
such  additional shares of Common Stock, Preferred  Stock,  other
capital stock, Convertible Securities or Options.  Any adjustment
under  this Section 2.2 will become effective on the record  date
or, if there is no record date, on the date of issuance.

      2.3   Reorganization, Reclassifications, Mergers or  Sales.
Any     recapitalization,    reorganization,    reclassification,
consolidation, merger, sale of all or substantially  all  of  the
Company's   assets  or  other  transaction  (including,   without
limitation,  any  Corporate Event (as  defined  in  the  Investor
Rights Agreement)), in each case that is effected in such  a  way
that  the holders of Common Stock are entitled to receive (either
directly  or  upon subsequent liquidation) stock,  securities  or
assets,  or a combination thereof, with respect to or in exchange
for Common

<PAGE> 2.6

Stock is referred to herein as an "Organic Change."  Prior to the
consummation  of  any Organic Change, other than  any  event  for
which  adjustment is made pursuant to Section 2.1 or 2.2  hereof,
the  Company  shall  make  appropriate  provision  (in  form  and
substance  reasonably satisfactory to the Holder) to ensure  that
the  Holder  shall  thereafter have  the  right  to  acquire  and
receive,  upon  exercise of this Warrant in accordance  with  its
terms  and upon payment of the Per Share Exercise Price  then  in
effect,  in  lieu  of  each  Share of  Common  Stock  immediately
theretofore acquirable and receivable upon the exercise  of  this
Warrant, such shares of stock, securities or assets as would have
been issued or payable with respect to each share of Common Stock
immediately  theretofore acquirable and receivable upon  exercise
of  the Warrant had the Warrant been exercised immediately  prior
to  such  Organic Change.  The Company shall not effect any  such
consolidation,  merger or sale, unless prior to the  consummation
thereof,  the  successor  entity  (if  other  than  the  Company)
resulting  from consolidation or merger or the entity  purchasing
such  assets  assumes by written instrument,  the  obligation  to
deliver to such Holder such shares of stock, securities or assets
as,  in accordance with the foregoing provisions, such Holder may
be entitled to acquire.

     2.4  Certain Events.  If (i) any event occurs of a type that
would  have  an effect on the rights granted under  this  Warrant
similar  to  the  effect  of any event  described  by  the  other
provisions of this Section 2 and (ii) such event is not expressly
provided  for  by  such  other provisions,  then  an  appropriate
adjustment  in  the Per Share Purchase Price and  the  number  of
shares  of Common Stock obtainable upon exercise of this  Warrant
so as to protect the rights of the Holder shall be made.  Without
limiting  the  generality  of the foregoing,  such  events  would
include the granting of stock appreciation rights, phantom  stock
rights or other rights with equity features.

     2.5  Notices.

          (a)  Within ten (10) business days of any adjustment of
the  Per  Share  Purchase Price, the Company shall  give  written
notice  thereof  to the Holder, setting forth and  certifying  in
reasonable  detail  the  facts causing such  adjustment  and  the
calculation  of  such  adjustment.  The  Company  will  give  due
consideration  to,  and  consult  with  counsel  regarding,   any
objection  the Holder may have to the matters described  in  such
notice,  and  will  make any corrections to  such  notice  deemed
necessary to conform with the terms of this Warrant.

           (b)   The  Company shall give written  notice  to  the
Holder at least ten (10) business days prior to the date on which
the  Company closes its books or takes a record (A) with  respect
to  any  dividend  or distribution (cash or otherwise)  upon  the
Common  Stock,  (B) with respect to any pro rata subscription  or
other  offer  to holders of Common Stock and (C) for  determining
rights to vote with respect to any Organic Change, dissolution or
liquidation.

           (c)  The Company shall also give written notice to the
Holder at least ten (10) business days prior to the date on which
any  Organic Change, dissolution or liquidation shall take place,
and,  for  so  long  as  Intel  or  any  of  its  Majority  Owned
Subsidiaries holds the Warrant or any portion thereof,  at  least
three  (3)  business days prior to the date  it  enters  into  an
agreement to do any of the foregoing.

<PAGE> 2.7

3.   TRANSFERABILITY OF WARRANT.

       3.1    Majority  Owned  Subsidiary.   A  "Majority   Owned
Subsidiary"  shall mean a subsidiary of which Intel  beneficially
owns,  either directly or indirectly, at least 50% of the  voting
power of all outstanding voting securities.  This Warrant may not
be  transferred or assigned in whole or in part, at any time, and
from  time  to  time,  except  to any Majority-Owned  Subsidiary.
Prior  to such time as any Majority-Owned Subsidiary shall  cease
to  be such, Intel shall cause such Majority-Owned Subsidiary  to
transfer  this  Warrant to Intel or any of Intel's Majority-Owned
Subsidiaries.

4.   MISCELLANEOUS.

      4.1   Legends.   Any  certificate for  Shares  issued  upon
exercise  hereof will be imprinted with a legend in substantially
the form set forth in the Common Stock Warrant Notice of Exercise
form attached hereto as Annex I.

     4.2  Investor Rights Agreement.  This Warrant and the Shares
are  subject to the terms and conditions of that certain Investor
Rights Agreement between the Company and Intel dated as of  March
18, 1997 (the "Investor Rights Agreement").

      4.3   Successors and Assigns.  The terms and provisions  of
this  Warrant will inure to the benefit of, and be binding  upon,
the  Company  and the Holder and their respective successors  and
assigns of the Holder and of the Company.

      4.4   Governing Law.  This Warrant will be governed by  and
construed  under  the  internal laws of the  State  of  Delaware,
without reference to principles of conflict of laws or choice  of
laws.

      4.5   Headings.   The headings and captions  used  in  this
Warrant  are  used  for  convenience  only  and  are  not  to  be
considered  in  construing  or interpreting  this  Warrant.   All
references  in this Warrant to sections and annexes will,  unless
otherwise  provided,  refer to sections and  hereof  and  annexes
attached hereto, all of which annexes are incorporated herein  by
this reference.

       4.6   Notices.   Unless  otherwise  provided,  any  notice
required  or  permitted  under this Warrant  shall  be  given  in
writing, shall be effective when received, and shall in any event
be  deemed received and effectively given upon personal  delivery
to  the  party  to be notified or three (3) business  days  after
deposit  with  the  United States Post Office, by  registered  or
certified  mail, postage prepaid, or one (1) business  day  after
deposit  with  a  nationally recognized courier service  such  as
Fedex  under circumstances in which such service guarantees  next
business  day  delivery, or one (1) business day after  facsimile
with  copy  delivered  by registered or certified  mail,  postage
prepaid  and addressed to the party to be notified at the address
indicated for such party on the signature page hereof or at  such
other  address  as the Investor or the Company may  designate  by
giving at least ten (10) days advance written notice pursuant  to
this Section 4.6.

<PAGE> 2.8

[The remainder of this page is intentionally left blank.]

<PAGE> 2.9

                                    STANDARD MICROSYSTEMS
                                    CORPORATION
                                    
                                    By:  _______________________
                                    
                                    Name:  _____________________
                                    
                                    Title:  ____________________
Accepted:                           
                                    
INTEL CORPORATION                   
                                    
By:  _______________________        
                                    
Name:  _____________________        
                                    
Title:  ____________________        


              [SIGNATURE PAGE COMMON STOCK WARRANT]
                                
<PAGE> 2.10

                            ANNEX TO
                             WARRANT
                                
                     ______________, 199___
                                
Standard Microsystems Corporation
80 Arkay Drive
Hauppauge, New York 11788

             Common Stock Warrant Notice of Exercise
             ---------------------------------------
                                
Gentlemen:

On  this  date  the  undersigned hereby  acquires  from  Standard
Microsystems Corporation, a Delaware corporation (the "Company"),
an  aggregate  of ________ shares of the Company's  Common  Stock
(the  "Warrant Shares"), by exercise, for such number of  shares,
of  that certain Warrant to Purchase Shares of Common Stock  (the
"Warrant"),  dated as of March 18, 1997 from the Company  to  the
original holder of the Warrant.  However, if this exercise of the
Warrant   is   subject   to   the   Hart-Scott-Rodino   Antitrust
Improvements  Act  of  1976 (the "HSR Act") filing  requirements,
this  Warrant shall be deemed to have been exercised on the  date
immediately  following  the  date  of  the  expiration  or  early
termination of all HSR Act restrictions.

1.    Investment Representations and Warranties.  The undersigned
represents and warrants that:

      1.1   Purchase for Own Account.  The Warrant Shares  to  be
purchased by the undersigned will be acquired for investment  for
the undersigned's own account, not as a nominee or agent, and not
with  a  view to the public resale or distribution thereof within
the  meaning of the Securities Act of 1933, as amended (the "1933
Act"),  and the undersigned has no present intention of  selling,
granting  any  participation  in, or otherwise  distributing  the
same.   The  undersigned also represents that  it  has  not  been
formed for the specific purpose of acquiring the Warrant Shares.

       1.2   Disclosure  of  Information.   The  undersigned  has
received  or  has  had  full access to  all  the  information  it
considers necessary or appropriate to make an informed investment
decision  with respect to the Warrant Shares to be  purchased  by
the undersigned.

      1.3   Investment  Experience.  The undersigned  understands
that  the  purchase  of  the Warrant Shares involves  substantial
risk.   The  undersigned:  (a) has experience as an  investor  in
securities of companies and acknowledges that it is able to  fend
for  itself, can bear the economic risk of its investment in  the
Warrant Shares and has such knowledge and experience in financial
or  business matters that it is capable of evaluating the  merits
and risks of this investment in the Warrant Shares and protecting
its  own interests in connection with this investment and/or  (b)
has  a  preexisting  personal or business relationship  with  the
Company  and  certain of its officers, directors  or  controlling
persons of a nature and duration that enables the

<PAGE> 2.11

undersigned  to  be aware of the character, business  acumen  and
financial circumstances of such persons.

      1.4   Accredited  Investor  Status.   The  Investor  is  an
"accredited   investor"  within  the  meaning  of  Regulation   D
promulgated under the 1933 Act.

      1.5   Restricted  Securities.  The undersigned  understands
that  the  Warrant  Shares  to be purchased  by  the  undersigned
hereunder, are characterized as "restricted securities" under the
1933 Act inasmuch as they are being acquired from the Company  in
a  transaction not involving a public offering and that under the
1933  Act  and applicable regulations thereunder such  securities
may  be  resold without registration under the 1933 Act  only  in
certain limited circumstances.  The undersigned is familiar  with
Rule 144 of the SEC, as presently in effect, and understands  the
resale  limitations imposed thereby and by  the  1933  Act.   The
undersigned  understands that the Company is under no  obligation
to  register  any  of  the securities sold  hereunder  except  as
provided in the Investor Rights Agreement between the Company and
Intel  Corporation dated as of March, 1997 (the "Investor  Rights
Agreement").

     1.6  Further Limitations on Disposition.  Without in any way
limiting  the  representations set forth above,  the  undersigned
further  agrees not to make any disposition of all or any portion
of the Warrant Shares unless and until:

           (a)   there is then in effect a registration statement
under  the 1933 Act covering such proposed disposition  and  such
disposition   is  made  in  accordance  with  such   registration
statement; or

           (b)   the undersigned has notified the Company of  the
proposed  disposition  and  has  furnished  the  Company  with  a
statement   of   the  circumstances  surrounding   the   proposed
disposition,  and the undersigned has furnished the  Company,  at
the expense of the undersigned or its transferee, with an opinion
of  counsel,  reasonably satisfactory to the Company,  that  such
disposition  will  not require registration  of  such  securities
under the 1933 Act.

Notwithstanding the provisions of paragraphs (a) and (b) of  this
Section 1.6, no such registration statement or opinion of counsel
will  be  required  for  any transfer of any  Warrant  Shares  in
compliance  with SEC Rule 144, Rule 144A or Rule  145(d),  or  if
such  transfer otherwise is exempt, in the view of the  Company's
legal  counsel, from the registration requirements  of  the  1933
Act.

      1.7   Investor Rights Agreement.    The undersigned  agrees
and acknowledges that the Warrant Shares are subject to the terms
and conditions or the Investor Rights Agreement.

2.    Legends.   The  undersigned understands  that  certificates
evidencing  the Warrant Shares will bear each of the legends  set
forth below:

      2.1   THE  SECURITIES  REPRESENTED  HEREBY  HAVE  NOT  BEEN
REGISTERED  UNDER  THE SECURITIES ACT OF 1933,  AS  AMENDED  (THE
"ACT"), OR

<PAGE> 2.12

UNDER  THE  SECURITIES LAWS OF CERTAIN STATES.  THESE  SECURITIES
ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY
NOT  BE  TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE  ACT
AND   THE   APPLICABLE  STATE  SECURITIES   LAWS,   PURSUANT   TO
REGISTRATION OR EXEMPTION THEREFROM.  INVESTORS SHOULD  BE  AWARE
THAT  THEY  MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS  OF  THIS
INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.  THE ISSUER OF THESE
SECURITIES  MAY  REQUIRE  AN  OPINION  OF  COUNSEL  IN  FORM  AND
SUBSTANCE  SATISFACTORY  TO THE ISSUER TO  THE  EFFECT  THAT  ANY
PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY
APPLICABLE STATE SECURITIES LAWS.

     2.2  THE SHARES EVIDENCED BY THIS CERTIFICATE ARE SUBJECT TO
CERTAIN  RESTRICTIONS  SPECIFIED IN  A  CERTAIN  INVESTOR  RIGHTS
AGREEMENT BETWEEN THE COMPANY AND INTEL CORPORATION DATED  AS  OF
March  18, 1997, A COPY OF WHICH IS AVAILABLE FOR EXAMINATION  AT
THE ISSUER'S PRINCIPAL OFFICE.

     2.3  Any legends required by any applicable state securities
laws.

The  undersigned  agrees that, to ensure and  enforce  compliance
with  the  restrictions  imposed  by  applicable  law  and  those
referred  to  in the foregoing legend, or elsewhere  herein,  the
Company may issue appropriate "stop transfer" instructions to its
transfer agent, if any, with respect to any certificate or  other
instrument representing Warrant Shares.

3.    Net  Exercise  Election.   If applicable,  the  undersigned
elects to purchase the Warrant Shares by Net Exercise (as defined
in  the  Warrant), by initialing in the following  space  (please
initial only if Net Exercise chosen): _________

4.    Same  Day  Sale Election.  If applicable,  the  undersigned
elects to purchase the Warrant Shares by "same day sale" pursuant
to the provisions of Section 1.3(b) of the Warrant, by initialing
on  the  following space (please initial only if  Same  Day  Sale
chosen): _________

By:  _______________________________

Name:  _____________________________

Title:  ____________________________

Address:  __________________________
          __________________________
          __________________________

Date signed:  ______________________


                         [SIGNATURE PAGE
            COMMON STOCK WARRANT NOTICE OF EXERCISE]
                                




                            EXHIBIT 3
                                
                                
                    INVESTOR RIGHTS AGREEMENT
<PAGE> 3.1
                            EXHIBIT B
                                
                STANDARD MICROSYSTEMS CORPORATION
                    INVESTOR RIGHTS AGREEMENT
                                
This  Investor Rights Agreement (this "Agreement")  is  made  and
entered  into  as  of  March 18, 1997, by  and  between  Standard
Microsystems Corporation, a Delaware corporation (the "Company"),
and Intel Corporation, a Delaware corporation (the "Investor").

                         R E C I T A L S
                         ---------------
                                
      A.    The Investor has agreed to purchase from the Company,
and the Company has agreed to sell to the Investor, shares of the
Company's  Common Stock (the "Common Stock") and a  Warrant  (the
"Warrant") on the terms and conditions set forth in that  certain
Common  Stock and Warrant Purchase Agreement, dated of even  date
herewith  by  and  between  the Company  and  the  Investor  (the
"Purchase Agreement").

     B.   The Purchase Agreement provides that the Investor shall
be  granted  certain information rights, registration rights  and
other rights, all as more fully set forth herein.

      NOW, THEREFORE, in consideration of the foregoing recitals,
the  mutual  promises hereinafter set forth, and other  good  and
valuable consideration, the receipt and sufficiency of which  are
hereby acknowledged, the parties hereto agree as follows:

1.   INFORMATION RIGHTS.

      1.1   Financial  Information.  The  Company  covenants  and
agrees  that,  commencing on the date of this Agreement,  for  so
long  as  the Investor holds shares of Common Stock issued  under
this  Agreement  or the Purchase Agreement or  shares  of  Common
Stock issued or issuable pursuant to exercise of the Warrant, the
Company will:

           (a)  Annual Reports.  Furnish to the Investor promptly
following the filing of such report with the U.S. Securities  and
Exchange  Commission (the "SEC"), a copy of the Company's  Annual
Report  on Form 10-K for each fiscal year, which shall include  a
consolidated Balance Sheet as of the end of such fiscal  year,  a
consolidated Statement of Income and a consolidated Statement  of
Cash  Flows  of the Company and its subsidiaries for  such  year,
setting  forth in each case in comparative form the figures  from
the  Company's  previous fiscal year, all prepared in  accordance
with  generally accepted accounting principles and practices  and
audited  by  nationally recognized independent  certified  public
accountants.   In  the  event  the Company  shall  no  longer  be
required to file Annual Reports on Form 10-K, the Company  shall,
within  ninety  (90)  days following the end of  each  respective
fiscal  year,  deliver  to the Investor a copy  of  such  Balance
Sheet, Statement of Income and Statement of Cash Flows.

<PAGE> 3.2

           (b)   Quarterly  Reports.   Furnish  to  the  Investor
promptly following the filing of such report with the SEC, a copy
of  each  of the Company's Quarterly Reports on Form 10-Q,  which
shall  include a consolidated Balance Sheet as of the end of  the
respective fiscal quarter, consolidated Statements of Income  and
consolidated  Statements of Cash Flows of  the  Company  and  its
subsidiaries for the respective fiscal quarter and for the  year-
to-date,  setting  forth  in each case in  comparative  form  the
figures  from the comparable periods in the Company's immediately
preceding  fiscal year, all prepared in accordance with generally
accepted  accounting principles and practices, but all  of  which
may  be  unaudited.  In the event the Company shall no longer  be
required  to  file  Quarterly Reports on Form 10-Q,  the  Company
shall,  within forty-five (45) days following the end of each  of
the  first three (3) fiscal quarters of each fiscal year, deliver
to  the  Investor  a  copy of such Balance Sheet,  Statements  of
Income and Statements of Cash Flows.

           (c)   SEC Filings.  The Company shall deliver  to  the
Investor  copies of each other document filed with  the  SEC  (as
defined  herein) promptly following the filing of  such  document
with the SEC.

     1.2  Board Observer.  So long as the Investor, together with
its  Majority Owned Subsidiaries (as defined in Section  6.1(c)),
holds at least the number of shares of the Company's Common Stock
equal  to  ten  percent  (10%) of the number  of  shares  of  the
Company's  Common  Stock and other voting securities  outstanding
immediately following the closing of the Purchase Agreement minus
100  shares (such number to be proportionately adjusted for stock
splits,  stock dividends, and similar events), the  Company  will
permit a representative of the Investor, reasonably acceptable to
the  Company  (the  "Observer") to attend  all  meetings  of  the
Company's  Board of Directors (the "Board") (whether  in  person,
telephonic or other) in a non-voting, observer capacity and shall
provide  to  the Investor, concurrently with the members  of  the
Board,  notice  of  such  meeting and a  copy  of  all  materials
provided  to such members.  For so long as the Investor shall  be
entitled  to  appoint an Observer pursuant to this  section,  the
Investor shall, by written election delivered to the Company,  be
entitled  to  designate  a  representative  for  appointment   or
election  to  the Board (the "Representative"), in  lieu  of  the
observer  contemplated  above.   Upon  written  request  of   the
Investor,  the Company shall use its reasonable best  efforts  to
cause the representative designated by the Investor to be elected
to  the Board, including recommending to the stockholders of  the
Company  that  they vote for the election to  the  Board  of  the
individual  designated by the Investor.   The  Company  shall  be
entitled  to recuse the Representative or Observer, as  the  case
may be, from portions of any Board meeting and to redact portions
of  Board  of Directors materials delivered to the Representative
or  Observer where and to the extent that a majority of the Board
(without  the  Representative or Observer present)  determines  a
conflict  of  interest between the Company and  the  Investor  is
present (but not where the conflict is a conflict that is present
for stockholders generally).  The Company acknowledged and agrees
that  the  Observer  shall  be acting  for  the  benefit  of  the
Investor, whose interests may not coincide with the interests  of
the  Company  and the other shareholders, and that  the  Observer
shall not be deemed to have breached any duty of any kind to  the
Company or its shareholders as a result of his or her acting in a
manner  he  or she deems to be in the interests of the  Investor.
Confidential  information  obtained  by  the  Representative   or
Observer shall be governed by the

<PAGE> 3.3

terms  of the Intel Corporation/Standard Microsystems Corporation
Corporate Non-Disclosure Agreement # 93761.

2.   REGISTRATION RIGHTS.

     2.1  Definitions.  For purposes of this Section 2:

          (a)  Registration.  The terms "register," "registered,"
and  "registration" refer to a registration effected by preparing
and  filing  a  registration statement  in  compliance  with  the
Securities  Act of 1933, as amended, (the "Securities Act"),  and
the declaration or ordering of effectiveness of such registration
statement

           (b)   Registrable  Securities.  The term  "Registrable
Securities"  means:  (l) all the shares of Common  Stock  of  the
Company issued or issuable (A) under the Purchase Agreement,  (B)
pursuant to an exercise of the Warrant (shares issued or issuable
upon  exercise  of  the Warrant are referred  to  herein  as  the
"Warrant Shares"), and (C) pursuant to the Right of Participation
(defined  in  Section  3  hereof) or  the  Right  of  Maintenance
(defined in Section 4 hereof), and (2) any shares of Common Stock
of  the  Company  issued as (or issuable upon the  conversion  or
exercise of any warrant, right or other security which is  issued
as)  a  dividend  or other distribution with respect  to,  or  in
exchange  for  or  in replacement of, any such shares  of  Common
Stock   described   in  clause  (1)  of  this   subsection   (b).
Notwithstanding  the  foregoing, "Registrable  Securities"  shall
exclude  any  Registrable  Securities  sold  by  a  person  in  a
transaction in which rights under this Section 2 are not assigned
in  accordance with this Agreement or any Registrable  Securities
sold  in  a  public offering, whether sold pursuant to  Rule  144
promulgated  under  the  Securities  Act,  or  in  a   registered
offering, or otherwise.

           (c)   Registrable  Securities Then  Outstanding.   The
number  of  shares  of "Registrable Securities then  outstanding"
shall  mean  the  number  of  shares of  Common  Stock  that  are
Registrable Securities and (l) are then issued and outstanding or
(2) are then issuable pursuant to an exercise of the Warrant.

           (d)  Holder.  For purposes of this Section 2, the term
"Holder" means any person owning of record Registrable Securities
that  have  not been sold to the public or pursuant to  Rule  144
promulgated under the Securities Act or any permitted assignee of
record  of such Registrable Securities to whom rights under  this
Section  2  have  been  duly assigned  in  accordance  with  this
Agreement.

           (e)   Form  S-3.  The term "Form S-3" means such  form
under  the  Securities Act as is in effect on the date hereof  or
any   successor  registration  form  under  the  Securities   Act
subsequently  adopted  by  the SEC  which  permits  inclusion  or
incorporation  of substantial information by reference  to  other
documents filed by the Company with the SEC.

           (f)   SEC.   The term "SEC" or "Commission" means  the
U.S. Securities and Exchange Commission.

<PAGE> 3.4

2.2  Demand Registration.

           (a)  Request by Holders.  If the Company shall at  any
time  after  the first anniversary of the Closing, as defined  in
the  Purchase  Agreement,  receive a  written  request  from  the
Holders  of at least twenty-five percent (25%) of the Registrable
Securities  then outstanding that the Company file a registration
statement  under the Securities Act covering the registration  of
Registrable  Securities pursuant to this Section  2.2,  then  the
Company  shall, within ten (10) business days of the  receipt  of
such  written  request,  give  written  notice  of  such  request
("Request  Notice") to all Holders, and use its best  efforts  to
effect,  as  soon  as  practicable, the  registration  under  the
Securities Act of all Registrable Securities that Holders request
to  be  registered and included in such registration  by  written
notice given such Holders to the Company within twenty (20)  days
after  receipt  of  the  Request  Notice,  subject  only  to  the
limitations  of  this Section 2.2; provided that the  Registrable
Securities requested by all Holders to be registered pursuant  to
such  request must be at least twenty-five percent (25%)  of  all
Registrable  Securities then outstanding;  and  provided  further
that  the  Company  shall not be obligated  to  effect  any  such
registration if the Company has, within the six (6) month  period
preceding   the  date  of  such  request,  already   effected   a
registration  under the Securities Act pursuant to  this  Section
2.2 or Section 2.4, or in which the Holders had an opportunity to
participate pursuant to the provisions of Section 2.3, other than
a  registration from which the Registrable Securities of  Holders
have  been  excluded (with respect to all or any portion  of  the
Registrable Securities the Holders requested be included in  such
registration) pursuant to the provisions of Section 2.3(a).

           (b)   Underwriting.   If  the Holders  initiating  the
registration   request  under  this  Section   2.2   ("Initiating
Holders") intend to distribute the Registrable Securities covered
by  their request by means of an underwriting, then they shall so
advise  the  Company as a part of their request made pursuant  to
this  Section 2.2 and the Company shall include such  information
in  the written notice referred to in subsection 2.2(a).  In such
event,  the  right  of  any  Holder to  include  his  Registrable
Securities  in such registration shall be conditioned  upon  such
Holder's participation in such underwriting and the inclusion  of
such  Holder's Registrable Securities in the underwriting (unless
otherwise  mutually  agreed  by a majority  in  interest  of  the
initiating  Holders  and  such Holder)  to  the  extent  provided
herein.   All  Holders proposing to distribute  their  securities
through  such  underwriting  shall  enter  into  an  underwriting
agreement  in  customary  form with the managing  underwriter  or
underwriters selected for such underwriting by the Holders  of  a
majority  of  the  Registrable Securities  being  registered  and
reasonably  acceptable to the Company (including a market  stand-
off   agreement   of  up  to  180  days  if  required   by   such
underwriters).   Notwithstanding  any  other  provision  of  this
Section  2.2,  if  the underwriter(s) advise(s)  the  Company  in
writing that marketing factors require a limitation of the number
of securities to be underwritten then the Company shall so advise
all  Holders  of Registrable Securities which would otherwise  be
registered  and underwritten pursuant hereto, and the  number  of
Registrable  Securities that may be included in the  underwriting
shall  be reduced as required by the underwriter(s) and allocated
among  the Holders of Registrable Securities on a pro rata  basis
according   to   the  number  of  Registrable   Securities   then
outstanding   held   by   each  Holder  requesting   registration
(including the initiating Holders); provided, however,  that  the
number of shares of Registrable Securities to be included in such
underwriting  and  registration shall not be reduced  unless  all
other securities of the Company are first entirely excluded  from
the

<PAGE> 3.5

underwriting   and  registration.   Any  Registrable   Securities
excluded  and withdrawn from such underwriting shall be withdrawn
from the registration.

           (c)   Maximum  Number  of Demand  Registrations.   The
Company  shall  be  obligated  to  effect  only  three  (3)  such
registrations pursuant to this Section 2.2.

           (d)  Deferral.  Notwithstanding the foregoing, if  the
Company  shall  furnish to Holders requesting  the  filing  of  a
registration   statement  pursuant  to  this   Section   2.2,   a
certificate signed by the President or Chief Executive Officer of
the Company stating that in the good faith judgment of the Board,
it  would  be  materially  detrimental to  the  Company  and  its
stockholders  for such registration statement to be  filed,  then
the  Company  shall  have the right to defer such  filing  for  a
period  of  not more than ninety (90) days after receipt  of  the
request  of the initiating Holders; provided, however,  that  the
Company  may not utilize this right more than once in any  twelve
(12) month period.

           (e)   Expenses.  All expenses incurred  in  connection
with  any  registration pursuant to this Section  2.2,  including
without  limitation  all  federal and  "blue  sky"  registration,
filing and qualification fees, printer's and accounting fees, and
fees  and disbursements of counsel for the Company (but excluding
underwriters' discounts and commissions relating to  shares  sold
by  the Holders and legal fees of counsel for the Holders), shall
be  borne  by  the  Company.   Each  Holder  participating  in  a
registration  pursuant  to  this  Section  2.2  shall  bear  such
Holder's proportionate share (based on the total number of shares
sold  in  such  registration other than for the  account  of  the
Company)  of all discounts, commissions or other amounts  payable
to  underwriters  or  brokers, and the Holders'  legal  fees,  in
connection  with  such offering by the Holders.   Notwithstanding
the  foregoing, the Company shall not be required to pay for  any
expenses  of any registration proceeding begun pursuant  to  this
Section 2.2 if the registration request is subsequently withdrawn
at  the  request of the Holders of a majority of the  Registrable
Securities to be registered, unless the Holders of a majority  of
the  Registrable  Securities  then outstanding  agree  that  such
registration constitutes the use by the Holders of one (1) demand
registration  pursuant to this Section 2.2 (in  which  case  such
registration  shall also constitute the use  by  all  Holders  of
Registrable  Securities  of  one (l) such  demand  registration);
provided,  further,  however,  that  if  at  the  time  of   such
withdrawal, the Holders have learned of a material adverse change
in the condition, business, or prospects of the Company not known
to the Holders at the time of their request for such registration
and have withdrawn their request for registration with reasonable
promptness  after learning of such material adverse change,  then
the Holders shall not be required to pay any of such expenses and
such  registration  shall not constitute  the  use  of  a  demand
registration pursuant to this Section 2.2.

      2.3  Piggyback Registrations.  The Company shall notify all
Holders of Registrable Securities in writing at least thirty (30)
days  prior  to  filing  any  registration  statement  under  the
Securities  Act  for purposes of effecting a public  offering  of
securities  of  the  Company  (including,  but  not  limited  to,
registration  statements  relating  to  secondary  offerings   of
securities  of the Company, but excluding registration statements
relating to any registration under Section 2.2 or Section 2.4  of
this Agreement, to any employee benefit plan or to any merger  or
other  corporate reorganization) and will afford each such Holder
an opportunity to include in

<PAGE> 3.6

such  registration statement all or any part of  the  Registrable
Securities  then  held by such Holder.  Each Holder  desiring  to
include in any such registration statement all or any part of the
Registrable  Securities held by such Holder shall  within  twenty
(20)  days after receipt of the above-described notice  from  the
Company,  so  notify the Company in writing, and in  such  notice
shall  inform the Company of the number of Registrable Securities
such Holder wishes to include in such registration statement.  If
a Holder decides not to include all of its Registrable Securities
in  any  registration statement thereafter filed by the  Company,
such  Holder  shall nevertheless continue to have  the  right  to
include any Registrable Securities in any subsequent registration
statement  or  registration statements as may  be  filed  by  the
Company with respect to offerings of its securities, all upon the
terms and conditions set forth herein.

           (a)   Underwriting.  If a registration statement under
which  the Company gives notice under this Section 2.3 is for  an
underwritten  offering,  then the Company  shall  so  advise  the
Holders  of Registrable Securities.  In such event, the right  of
any  such  Holder's Registrable Securities to be  included  in  a
registration  pursuant to this Section 2.3 shall  be  conditioned
upon  such  Holder's participation in such underwriting  and  the
inclusion  of  such  Holder's  Registrable  Securities   in   the
underwriting  to  the  extent  provided  herein.    All   Holders
proposing to distribute their Registrable Securities through such
underwriting  shall  enter  into  an  underwriting  agreement  in
customary  form  with  the managing underwriter  or  underwriters
selected  for  such  underwriting (including a  market  stand-off
agreement  of  up to 180 days if required by such  underwriters).
Notwithstanding  any other provision of this  Agreement,  if  the
managing  underwriter determine(s) in good faith  that  marketing
factors  require  a  limitation of the number  of  shares  to  be
underwritten, then the managing underwriter(s) may exclude shares
from  the  registration and the underwriting, and the  number  of
shares  that  may  be  included  in  the  registration  and   the
underwriting  shall  be  allocated, first  to  the  Company,  and
second,  to each of the Holders and other holders of registration
rights on a parity with the Holders requesting inclusion of their
Registrable Securities in such registration statement  on  a  pro
rata  basis  based on the total number of Registrable  Securities
and  other securities entitled to registration then held by  each
such Holder or other holder; provided, however, that the right of
the   underwriters  to  exclude  shares  (including   Registrable
Securities)  from the registration and underwriting as  described
above  shall  be restricted so that (i) the number of Registrable
Securities included in any such registration is not reduced below
twenty-five  percent (25%) of the aggregate number of Registrable
Securities for which inclusion has been requested; and  (ii)  all
shares  that are not Registrable Securities and are held  by  any
other person, including, without limitation, any person who is an
employee,  officer or director of the Company (or any  subsidiary
of  the  Company) shall first be excluded from such  registration
and  underwriting  before  any  Registrable  Securities  are   so
excluded  (other  than to the extent that such persons  are  non-
employee directors or other non-employees of the Company who hold
registration  rights  on  a parity with the  Holders,  such  non-
employee  directors  and other non-employees  being  entitled  to
participate with the participating Holders on the basis described
under "second" above).  If any Holder disapproves of the terms of
any   such  underwriting,  such  Holder  may  elect  to  withdraw
therefrom  by  written notice to the Company and the underwriter,
delivered  at least ten (10) business days prior to the effective
date  of  the registration statement.  Any Registrable Securities
excluded  or  withdrawn from such underwriting shall be  excluded
and  withdrawn from the registration.  For any Holder that  is  a
partnership, the Holder and the partners and retired partners  of
such Holder, or the estates and

<PAGE> 3.7

family members of any such partners and retired partners and  any
trusts  for the benefit of any of the foregoing persons, and  for
any Holder that is a corporation, the Holder and all corporations
that  are  affiliates of such Holder, shall be  deemed  to  be  a
single "Holder," and any pro rata reduction with respect to  such
"Holder"  shall  be  based upon the aggregate  amount  of  shares
carrying   registration  rights  owned  by   all   entities   and
individuals  included  in  such  "Holder,"  as  defined  in  this
sentence.

           (b)   Expenses.  All expenses incurred  in  connection
with  a  registration  pursuant to this  Section  2.3  (excluding
underwriters' and brokers' discounts and commissions relating  to
shares  sold  by  the Holders and legal fees of counsel  for  the
Holders),  including, without limitation all  federal  and  "blue
sky"  registration, filing and qualification fees, printers'  and
accounting  fees, and fees and disbursements of counsel  for  the
Company, shall be borne by the Company.

          (c)  Not Demand Registration.  Registration pursuant to
this  Section 2.3 shall not be deemed to be a demand registration
as  described in Section 2.2 above.  Except as otherwise provided
herein,  there  shall  be no limit on the  number  of  times  the
Holders may request registration of Registrable Securities  under
this Section 2.3.

      2.4   Form S-3 Registration.  In case the Company shall  at
any  time after the first anniversary of the Closing, as  defined
in  the Purchase Agreement, receive from any Holder or Holders of
a  majority  of  all  Registrable Securities then  outstanding  a
written   request   or  requests  that  the  Company   effect   a
registration  on  Form  S-3  and  any  related  qualification  or
compliance  with  respect  to all or a part  of  the  Registrable
Securities  owned  by such Holder or Holders,  then  the  Company
will:

           (a)   Notice.   Promptly give written  notice  of  the
proposed  registration  and  the  Holder's  or  Holders'  request
therefor,  and  any related qualification or compliance,  to  all
other Holders of Registrable Securities; and

          (b)  Registration.  As soon as practicable, effect such
registration and all such qualifications and compliances  as  may
be  so  requested and as would permit or facilitate the sale  and
distribution of all or such portion of such Holders  or  Holders'
Registrable Securities as are specified in such request, together
with  all  or such portion of the Registrable Securities  of  any
other  Holder or Holders joining in such request as are specified
in  a  written  request given within twenty (20) days  after  the
Company  provides  the  notice contemplated  by  Section  2.4(a);
provided,  however, that the Company shall not  be  obligated  to
effect   any   such  registration,  qualification  or  compliance
pursuant to this Section 2.4:

                (1)   if  Form  S-3  is not  available  for  such
offering by the Holders:

                (2)  if the Holders, together with the holders of
any other securities of the Company entitled to inclusion in such
registration,  propose to sell Registrable  Securities  and  such
other securities (if any) at an aggregate price to the public  of
less than $5,000,000;

<PAGE> 3.8

               (3)  if the Company shall furnish to the Holders a
certificate signed by the President or Chief Executive Officer of
the  Company stating that in the good faith judgment of the Board
of  Directors of the Company, it would be materially  detrimental
to   the   Company  and  its  shareholders  for  such  Form   S-3
Registration  to  be effected at such time, in  which  event  the
Company shall have the right to defer the filing of the Form  S-3
registration statement no more than once during any twelve  month
period  for  a  period of not more than ninety  (90)  days  after
receipt  of  the  request of the Holder  or  Holders  under  this
Section 2.4;

                (4)  if the Company has, within the six (6) month
period  preceding  the date of such request, already  effected  a
registration  under the Securities Act other than a  registration
from  which  the  Registrable Securities  of  Holders  have  been
excluded  (with respect to all or any portion of the  Registrable
Securities   the   Holders  requested   be   included   in   such
registration) pursuant to the provisions of Section 2.3(a); or

                (5)  in any particular jurisdiction in which  the
Company would be required to qualify to do business or to execute
a  general  consent  to  service of  process  in  effecting  such
registration, qualification or compliance.

           (c)   Expenses.   The Company shall pay  all  expenses
incurred  in connection with each registration requested pursuant
to   this  Section  2.4,  (excluding  underwriters'  or  brokers'
discounts and commissions relating to shares sold by the  Holders
and  legal  fees  of counsel for the Holders), including  without
limitation  federal  and  "blue  sky"  registration,  filing  and
qualification fees, printers' and accounting fees, and  fees  and
disbursements of counsel.

           (d)  Deferral.  Notwithstanding the foregoing, if  the
Company  shall  furnish to Holders requesting  the  filing  of  a
registration   statement  pursuant  to  this   Section   2.4,   a
certificate signed by the President or Chief Executive Officer of
the Company stating that in the good faith judgment of the Board,
it  would  be  materially  detrimental to  the  Company  and  its
stockholders  for such registration statement to be  filed,  then
the  Company  shall  have the right to defer such  filing  for  a
period  of  not more than ninety (90) days after receipt  of  the
request  of the initiating Holders; provided, however,  that  the
Company  may not utilize this right more than once in any  twelve
(12) month period.

           (e)   Not Demand Registration.  Form S-3 registrations
shall  not  be deemed to be demand registrations as described  in
Section  2.2 above.  Except as otherwise provided herein, Holders
may  request  up  to  3  separate  registrations  of  Registrable
Securities under this Section 2.4.

      2.5   Obligations  of  the Company.  Whenever  required  to
effect the registration of any Registrable Securities under  this
Agreement  the  Company  shall, as  expeditiously  as  reasonably
possible:

          (a)  Registration Statement.  Prepare and file with the
SEC  a  registration statement with respect to  such  Registrable
Securities  and  use its best efforts to cause such  registration
statement  to  become  effective,  provided,  however,  that  the
Company  shall  not  be  required to keep any  such  registration
statement effective for more than ninety (90) days.

<PAGE> 3.9

          (b)  Amendments and Supplements.  Prepare and file with
the  SEC  such  amendments and supplements to  such  registration
statement  and  the  prospectus  used  in  connection  with  such
registration  statement as may be necessary to  comply  with  the
provisions  of the Securities Act with respect to the disposition
of all securities covered by such registration statement.

           (c)  Prospectuses.  Furnish to the Holders such number
of copies of a prospectus, including a preliminary prospectus, in
conformity with the requirements of the Securities Act, and  such
other  documents  as  they may reasonably  request  in  order  to
facilitate the disposition of the Registrable Securities owned by
them that are included in such registration.

           (d)   Blue Sky.  Use its best efforts to register  and
qualify  the  securities  covered by such registration  statement
under   such   other  securities  or  Blue  Sky  laws   of   such
jurisdictions  as shall be reasonably requested by  the  Holders,
provided  that  the Company shall not be required  in  connection
therewith or as a condition thereto to qualify to do business  or
to  file  a  general consent to service of process  in  any  such
states or jurisdictions.

           (e)   Underwriting.  In the event of any  underwritten
public offering, enter into and perform its obligations under  an
underwriting  agreement  in usual and customary  form,  with  the
managing   underwriter(s)   of  such   offering.    Each   Holder
participating  in  such underwriting shall also  enter  into  and
perform its obligations under such an agreement.

           (f)   Notification.  Notify each Holder of Registrable
Securities  covered by such registration statement  at  any  time
when  a  prospectus relating thereto is required to be  delivered
under  the  Securities Act of the happening of  any  event  as  a
result  of  which  the prospectus included in  such  registration
statement, as then in effect, includes an untrue statement  of  a
material  fact or omits to state a material fact required  to  be
stated  therein or necessary to make the statements  therein  not
misleading in the light of the circumstances then existing.

           (g)   Opinion  and Comfort Letter.   Furnish,  at  the
request  of  any  Holder requesting registration  of  Registrable
Securities,  on  the  date that such Registrable  Securities  are
delivered  to  the underwriters for sale, if such securities  are
being  sold through underwriters, or, if such securities are  not
being   sold   through  underwriters,  on  the  date   that   the
registration  statement with respect to such  securities  becomes
effective, (i) an opinion, dated as of such date, of the  counsel
representing  the Company for the purposes of such  registration,
in  form and substance as is customarily given to underwriters in
an underwritten public offering and reasonably satisfactory to  a
majority  in  interest  of  the Holders requesting  registration,
addressed  to  the  underwriters, if  any,  and  to  the  Holders
requesting  registration of Registrable  Securities  and  (ii)  a
"comfort"  letter  dated as of such date,  from  the  independent
certified  public  accountants  of  the  Company,  in  form   and
substance as is customarily given by independent certified public
accountants  to  underwriters in an underwritten public  offering
and  reasonably  satisfactory to a majority in  interest  of  the
Holders  requesting registration, addressed to the  underwriters,
if any, and to the Holders requesting registration of Registrable
Securities.

     2.6  Furnish Information.  It shall be a condition precedent
to  the obligations of the Company to take any action pursuant to
Sections 2.2, 2.3 or 2.4 that the selling Holders shall

<PAGE> 3.10

furnish to the Company such information regarding themselves, the
Registrable Securities held by them, and the intended  method  of
disposition  of  such securities as shall be required  to  timely
effect the Registration of their Registrable Securities.

       2.7    Indemnification.   In  the  event  any  Registrable
Securities  are  included  in  a  registration  statement   under
Sections 2.2, 2.3 or 2.4:

           (a)   By the Company.  To the extent permitted by law;
the  Company  will indemnify and hold harmless each  Holder,  the
partners,  officers and directors of each Holder, any underwriter
(as  determined in the Securities Act) for such Holder  and  each
person,  if  any, who controls such Holder or underwriter  within
the  meaning of the Securities Act or the Securities Exchange Act
of  1934,  as  amended,  (the "1934 Act"),  against  any  losses,
claims, damages, or Liabilities (joint or several) to which  they
may  become  subject under the Securities Act, the  1934  Act  or
other  federal  or  state law, insofar as  such  losses,  claims,
damages, or liabilities (or actions in respect thereof) arise out
of  or  are based upon any of the following statements, omissions
or violations (collectively a "Violation"):

                (i)   any  untrue  statement  or  alleged  untrue
          statement  of  a  material  fact  contained   in   such
          registration   statement,  including  any   preliminary
          prospectus or final prospectus contained therein or any
          amendments or supplements thereto;
          
                (ii)  the omission or alleged omission  to  state
          therein  a material fact required to be stated therein,
          or   necessary  to  make  the  statements  therein  not
          misleading, or
          
                (iii)      any violation or alleged violation  by
          the  Company of the Securities Act, the 1934  Act,  any
          federal  or  state  securities  law  or  any  rule   or
          regulation  promulgated under the Securities  Act,  the
          1934  Act  or  any federal or state securities  law  in
          connection   with   the  offering   covered   by   such
          registration statement;
          
and the Company will reimburse each such Holder, partner, officer
or  director, underwriter or controlling person for any legal  or
other  expenses  reasonably incurred by  them,  as  incurred,  in
connection with investigating or defending any such loss,  claim,
damage,   liability  or  action;  provided,  however,  that   the
indemnity agreement contained in this subsection 2.7(a) shall not
apply  to  amounts  paid in settlement of any such  loss,  claim,
damage,  liability  or  action  if such  settlement  is  effected
without  the consent of the Company (which consent shall  not  be
unreasonably  withheld), nor shall the Company be liable  in  any
such  case for any such loss, claim, damage, liability or  action
to  the extent that it arises out of or is based upon a Violation
which  occurs  in  reliance upon and in conformity  with  written
information furnished expressly for use in connection  with  such
registration   by   such  Holder,  partner,  officer,   director,
underwriter or controlling person of such Holder.

           (b)   By Selling Holders.  To the extent permitted  by
law,  each  selling Holder will indemnify and hold  harmless  the
Company,  each  of its directors, each of its officers  who  have
signed  the  registration statement, each  person,  if  any,  who
controls the Company within the

<PAGE> 3.11

meaning  of  the Securities Act, any underwriter  and  any  other
Holder  selling securities under such registration  statement  or
any of such other Holder's partners, directors or officers or any
person  who  controls  such  Holder within  the  meaning  of  the
Securities  Act  or  the 1934 Act, against  any  losses,  claims,
damages or liabilities (joint or several) to which the Company or
any  such  director, officer, controlling person, underwriter  or
other  such  Holder, partner or director, officer or  controlling
person  of  such  other  Holder  may  become  subject  under  the
Securities  Act,  the  1934 Act or other federal  or  state  law,
insofar  as  such  losses,  claims, damages  or  liabilities  (or
actions  in respect thereto) arise out of or are based  upon  any
Violation,  in each case to the extent (and only to  the  extent)
that  such  Violation occurs in reliance upon and  in  conformity
with  written information furnished by such Holder expressly  for
use  in  connection with such registration; and each such  Holder
will reimburse any legal or other expenses reasonably incurred by
the  Company  or any such director, officer, controlling  person,
underwriter  or  other  Holder,  partner,  officer,  director  or
controlling  person  of  such other  Holder  in  connection  with
investigating   or  defending  any  such  loss,  claim,   damage,
liability  or  action:  provided,  however,  that  the  indemnity
agreement contained in this subsection 2.7(b) shall not apply  to
amounts  paid  in  settlement of any such  loss,  claim,  damage,
liability  or action if such settlement is effected  without  the
consent  of  the Holder, which consent shall not be  unreasonably
withheld;  and provided, further, that the total amounts  payable
in  indemnity by a Holder under this Section 2.7(b) in respect of
any  Violation shall not exceed the net proceeds received by such
Holder  in  the  registered offering out of which such  Violation
arises.

           (c)  Notice.  Promptly after receipt by an indemnified
party under this Section 2.7 of notice of the commencement of any
action  (including  any  governmental action),  such  indemnified
party  will, if a claim in respect thereof is to be made  against
any  indemnifying party under this Section 2.7,  deliver  to  the
indemnifying  party a written notice of the commencement  thereof
and  the  indemnifying party shall have the right to  participate
in, and, to the extent the indemnifying party so desires, jointly
with  any  other indemnifying party similarly noticed, to  assume
the  defense  thereof with counsel mutually satisfactory  to  the
parties; provided, however, that an indemnified party shall  have
the  right to retain its own counsel, with the fees and  expenses
to  be  paid  by  the  indemnifying party,  to  the  extent  that
representation of such indemnified party by the counsel  retained
by the indemnifying party would be inappropriate due to actual or
potential  conflict of interests between such  indemnified  party
and   any  other  party  represented  by  such  counsel  in  such
proceeding.   The  failure  to  deliver  written  notice  to  the
indemnifying  party within a reasonable time of the  commencement
of  any  such  action  shall relieve such indemnifying  party  of
liability to the indemnified party under this Section 2.7 to  the
extent  the indemnifying party is prejudiced as a result thereof,
but  the omission so to deliver written notice to the indemnified
party  will not relieve it of any liability that it may  have  to
any indemnified party otherwise than under this Section 2.7.

           (d)   Defect  Eliminated  in  Final  Prospectus.   The
foregoing  indemnity agreements of the Company  and  Holders  are
subject  to  the condition that, insofar as they  relate  to  any
Violation  made  in  a preliminary prospectus but  eliminated  or
remedied  in the amended prospectus on file with the SEC  at  the
time the registration statement in question becomes effective  or
the  amended prospectus filed with the SEC pursuant to  SEC  Rule
424(b)  (the "Final Prospectus"), such indemnity agreement  shall
not inure to the benefit of any person if a copy of

<PAGE> 3.12

the  Final  Prospectus was timely furnished  to  the  indemnified
party  and  was not furnished to the person asserting  the  loss,
liability, claim or damage at or prior to the time such action is
required by the Securities Act.

           (e)   Contribution.  In order to provide for just  and
equitable  contribution to joint liability under  the  Securities
Act  in any case in which either (i) any Holder exercising rights
under  this  Agreement, or any controlling  person  of  any  such
Holder,  makes  a  claim  for indemnification  pursuant  to  this
Section  2.7 but it is judicially determined (by the entry  of  a
final judgment or decree by a court of competent jurisdiction and
the  expiration of time to appeal or the denial of the last right
of  appeal) that such indemnification may not be enforced in such
case notwithstanding the fact that this Section 2.7 provides  for
indemnification  in  such case, or (ii)  contribution  under  the
Securities  Act may be required on the part of any  such  selling
Holder or any such controlling person in circumstances for  which
indemnification is provided under this Section 2.7; then, and  in
each  such  case, the Company and such Holder will contribute  to
the  aggregate  losses, claims, damages or liabilities  to  which
they  may  be  subject (after contribution from others)  in  such
proportion  so  that such Holder is responsible for  the  portion
represented by the percentage that the public offering  price  of
its   Registrable  Securities  offered  by  and  sold  under  the
registration statement bears to the public offering price of  all
securities offered by and sold under such registration statement,
and the Company and other selling Holders are responsible for the
remaining portion; provided, however, that, in any such case: (A)
no  such  Holder  will be required to contribute  any  amount  in
excess  of  the  public  offering price of all  such  Registrable
Securities  offered  and  sold by such Holder  pursuant  to  such
registration  statement; and (B) no person or  entity  guilty  of
fraudulent misrepresentation (within the meaning of Section 11(f)
of  the Securities Act) will be entitled to contribution from any
person   or   entity  who  was  not  guilty  of  such  fraudulent
misrepresentation.

           (f)   Survival.   The obligations of the  Company  and
Holders  under  this Section 2.7 shall survive  until  the  fifth
anniversary  of  the  completion of any offering  of  Registrable
Securities  in  a  registration  statement,  regardless  of   the
expiration  of any statutes of limitation or extensions  of  such
statutes.

      2.8  Termination of the Company's Obligations.  The Company
shall have no obligations pursuant to this Section 2 with respect
to  any Registrable Securities proposed to be sold by a Holder in
a  registration  pursuant to Section 2.2, 2.3 or  2.4  more  than
seven (7) years after the date of this Agreement, or, if, in  the
opinion   of   counsel  to  the  Company,  all  such  Registrable
Securities proposed to be sold by a Holder may then be sold under
Rule   144  in  one  transaction  without  exceeding  the  volume
limitations thereunder.

      2.9  No Registration Rights to Third Parties.  Without  the
prior written consent of the Holders of a majority in interest of
the   Registrable  Securities  then  outstanding,   the   Company
covenants and agrees that it shall not grant, or cause or  permit
to  be  created,  for  the benefit of any person  or  entity  any
registration rights of any kind (whether similar to  the  demand,
"piggyback"  or  Form S-3 registration rights described  in  this
Article  2,  or  otherwise) relating to shares of  the  Company's
Common Stock or any other voting securities of the Company, other
than rights that are on a parity with or subordinate in right  to
the Holders.

<PAGE> 3.13

3.   RIGHT OF PARTICIPATION.

       3.1    General.   The  Investor  and  any  Majority  Owned
Subsidiary of the Investor to which rights under this  Section  3
have  been  duly  assigned  in accordance  with  Section  6  (the
Investor and each such assignee being hereinafter referred to  as
a  "Participation Rights Holder") shall have the right  of  first
refusal  to purchase such Participation Rights Holder's Pro  Rata
Share  (as  defined  below), of all (or  any  part)  of  any  New
Securities (as defined in Section 3.3) that the Company may  from
time  to time issue after the date of this Agreement (the  "Right
of  Participation");  provided, however,  that  no  Participation
Rights  Holder shall have the Right of Participation with respect
to  any issuance of New Securities that would result in less than
a  five  percent  (5%)  reduction in  such  Participation  Rights
Holder's Pro Rata Share.

      3.2   Pro Rata Share.  A Participation Rights Holder's "Pro
Rata  Share"  for purposes of the Right of Participation  is  the
ratio  of (a) the number of Registrable Securities held  by  such
Participation  Rights Holder, to (b) the difference  between  (i)
the  total  number of shares of Common Stock of the Company  (and
other  voting securities of the Company, if any) then outstanding
(immediately prior to the issuance of New Securities giving  rise
to  the  Right  of  Participation), where for such  purposes  all
Warrant  Shares  held  by  the Investor and  its  Majority  Owned
Subsidiaries  are  deemed outstanding, and  (ii)  the  number  of
Dilutive Securities (defined below) issued since the last  Notice
Date   (defined  below)  excluding  any  Maintenance   Securities
(defined below) issued pursuant to the last Maintenance Notice.

     3.3  New Securities.  "New Securities" shall mean any Common
Stock,  Preferred  Stock or other voting  capital  stock  of  the
Company,  whether now authorized or not, and rights,  options  or
warrants  to purchase such Common Stock or Preferred  Stock,  and
securities  of  any  type whatsoever that  are,  or  may  become,
convertible  or  exchangeable into such Common  Stock,  Preferred
Stock  or  other capital stock, provided, however, that the  term
"New Securities" shall not include:

           (a)   any shares of the Company's Common Stock (and/or
options  or  warrants  therefor) issued  to  employees  officers,
directors,  contractors, advisors or consultants of  the  Company
pursuant  to incentive agreements or incentive plans approved  by
the Board;

           (b)   any  shares  of Common Stock  issued  under  the
Purchase Agreement, as such agreement may be amended;

           (c)   the Warrant or any shares of Common Stock issued
upon any exercise thereof;

          (d)  any securities issued in connection with any stock
split  stock,  dividend  or  other similar  event  in  which  all
Participation Rights Holders are entitled to participate on a pro
rata basis;

            (e)    any   securities  issued  upon  the  exercise,
conversion  or  exchange  of  any outstanding  security  if  such
outstanding security constituted a New Security;

<PAGE> 3.14

           (f)  any securities issued pursuant to the acquisition
of another corporation or entity by the Company by consolidation,
merger, purchase of assets, or other reorganization in which  the
Company  acquires, in a single transaction or series  of  related
transactions, assets of such other corporation or entity or fifty
percent  (50%)  or  more  of  the  voting  power  of  such  other
corporation  or  entity or fifty percent (50%)  or  more  of  the
equity ownership of such other entity; or

           (g)   any  securities issued pursuant to the Company's
"Shareholder  Rights  Plan"  in which  all  Participation  Rights
Holders are entitled to participate on a pro rata basis.

      3.4  Procedures.  In the event that the Company proposes to
undertake  an issuance of New Securities (in a single transaction
or  a series of related transactions) that would result in a five
percent  (5%) or greater reduction in the Pro Rata Share of  each
Participation  Rights Holder, it shall give to each Participation
Rights  Holder  written  notice of its  intention  to  issue  New
Securities  (the "Participation Notice"), describing  the  amount
and  the  type  of New Securities and the price and  the  general
terms  upon  which  the  Company  proposes  to  issue  such   New
Securities. Each Participation Rights Holder shall have ten  (10)
business  days from the date of receipt of any such Participation
Notice  to agree in writing to purchase such Participation Rights
Holder's Pro Rata Share of such New Securities for the price  and
upon  the  terms  and conditions specified in  the  Participation
Notice  by  giving  written notice to  the  Company  and  stating
therein  the quantity of New Securities to be purchased  (not  to
exceed  such Participation Rights Holder's Pro Rata  Share).   If
any  Participation  Rights Holder fails to so  agree  in  writing
within  such  ten  (10)  business day  period  to  purchase  such
Participation Rights Holder's full Pro Rata Share of an  offering
of  New  Securities, then such Participation Rights Holder  shall
forfeit the right hereunder to purchase that part of its Pro Rata
Share  of  such  New  Securities that it  did  not  so  agree  to
purchase.   Such Participation Rights Holder shall  purchase  the
portion  elected by such Participation Rights Holder concurrently
with  the  closing  of the transaction triggering  the  Right  of
Participation.

      3.5  Failure to Exercise.  Upon the expiration of such  ten
(10)  day  period, the Company shall have 120 days thereafter  to
sell  the  New  Securities described in the Participation  Notice
(with  respect to which the Participation Rights Holders'  rights
of  first refusal hereunder were not exercised), or enter into an
agreement to do so, within sixty (60) days thereafter, at no less
than  one-hundred percent (100%) of the price and upon  non-price
terms  not  materially more favorable to the  purchasers  thereof
than  specified in the Participation Notice.  In the  event  that
the  Company  has not issued and sold such New Securities  within
such 120 day period, or entered into an agreement to do so within
sixty (60) days thereafter, then the Company shall not thereafter
issue  or  sell  any New Securities without again first  offering
such  New Securities to the Participation Rights Holders pursuant
to this Section 3.

      3.6   Termination.   The  Right of  Participation  for  the
Investor  and  each  other  Participation  Rights  Holder   shall
terminate upon the date that the Investor and its Affiliates  (as
defined  in Rule 144 under the Securities Act) collectively  hold
less  than  the  number of shares of the Company's  Common  Stock
equal to ten percent (10%) of the number of shares of the

<PAGE> 3.15

Company's  Common  Stock and other voting securities  outstanding
immediately following the closing of the Purchase Agreement minus
100  shares (such number to be proportionately adjusted for stock
splits, stock dividends and similar events).

4.   RIGHT OF MAINTENANCE.

      4.1   General.   Each  Participation  Rights  Holder  will,
pursuant to the terms and conditions of this Section 4, have  the
right  to purchase shares of Common Stock, voting Preferred Stock
or other voting capital stock ("Maintenance Securities") from the
Company  at  the  Purchase  Price (as  defined  in  Section  4.3)
following the issuance by the Company of Dilutive Securities  (as
defined  in Section 4.2) that the Company may from time  to  time
issue  after  the  date of this Agreement,  solely  in  order  to
maintain  such  Participation Rights  Holder's  Prior  Percentage
Interest  (as defined in Section 4.4) in the Company (the  "Right
of  Maintenance").  Each right to purchase Maintenance Securities
pursuant to this Section 4 shall be on the same terms (other than
price  to  the  extent  provided in Section  4.3  below)  as  the
issuance  of the Dilutive Securities that gave rise to the  right
to purchase such Maintenance Securities

      4.2  Dilutive Securities.  "Dilutive Securities" means  any
Common  Stock,  voting  Preferred Stock or other  voting  capital
stock  of  the Company, whether now authorized or not;  provided,
however, that the term "Dilutive Securities" does not include:

           (a)   any  securities other than Common Stock,  voting
Preferred Stock or other voting capital stock (e.g.,  warrants or
options  to  purchase  Common Stock,  Preferred  Stock  or  other
capital stock);

           (b)   any  shares  of Common Stock  issued  under  the
Purchase Agreement, as such agreement may be amended;

          (c)  the Warrant or any shares of Common Stock issuable
upon any exercise thereof;

          (d)  any securities issued in connection with any stock
split, stock dividend or similar event in which all Participation
Rights Holders are entitled to participate on a pro rata basis;

          (e)  any securities for which the issuance gave rise to
the  Right of Participation (regardless of whether any such right
was exercised); or

            (f)   any  securities  issuable  upon  the  exercise,
conversion or exchange of any securities described in (d) or  (e)
above.

     4.3  Purchase Price.

           (a)  Employee Stock.  To the extent that the right  to
purchase  Maintenance Securities arises out of  the  issuance  of
Dilutive    Securities   to   employees,   officers,   directors,
contractors, advisors or consultants of the Company  pursuant  to
incentive agreements or

<PAGE> 3.16

incentive plans approved by the Board ("Employee Stock"), the per
share  "Purchase Price" of the Maintenance Securities shall equal
the  average  Market Price (as defined below) of such Maintenance
Securities  over the ten (10) trading days immediately  preceding
the  date  on  which the Participation Rights  Holder  elects  to
purchase such Maintenance Securities.

          (b)  Other Dilutive Securities.  To the extent that the
right  to  purchase  Maintenance Securities  arises  out  of  any
issuance  of Dilutive Securities other than Employee  Stock,  the
per  share  "Purchase Price" of the Maintenance Securities  shall
equal  the  lower of (i) the weighted average of  the  per  share
prices  at which such Dilutive Securities were issued,  and  (ii)
the  average  Market Price (as defined below) of such Maintenance
Securities  over the ten (10) trading days immediately  preceding
the  date  on  which the Participation Rights  Holder  elects  to
purchase  such Maintenance Securities.  For purposes  hereof,  in
the  event  that  the issuance of any Dilutive Securities  occurs
upon  the  exercise, conversion or exchange of  other  securities
("Exchangeable  Securities"), then the per share price  at  which
such  Dilutive  Securities shall be deemed to  have  been  issued
shall  be  the  sum of (A) the per share amount  paid  upon  such
exercise,  conversion or exchange, plus (B) the per share  amount
previously paid for the Exchangeable Securities (adjusted for any
stock splits, stock dividends or other similar events).

           (c)   Market Price. For purposes of this Section  4.3,
"Market Price" means, as to any Maintenance Securities on a given
day,  the average of the closing prices of such security's  sales
on  all domestic securities exchanges on which such security  may
at  the  time be listed, or, if there have been no sales  on  any
such  exchange  on such day, the average of the highest  bid  and
lowest asked prices on all such exchanges at the end of such day,
or, if on any day such security is not so listed, the average  of
the  representative  bid and asked prices quoted  in  the  NASDAQ
National Market as of 4:00 P.M., New York time, on such day,  or,
if  on any day such security is not quoted in the NASDAQ National
Market, the average of the highest bid and lowest asked prices on
such  day in the domestic over-the-counter market as reported  by
the  National  Quotation  Bureau, Incorporated,  or  any  similar
successor   organization.   If  at  any  time   the   Maintenance
Securities are not listed on any domestic securities exchange  or
quoted  in  the NASDAQ National Market or the domestic  over-the-
counter market ("Unlisted Securities"), the "Market Price"  shall
be  the fair value thereof determined jointly by the Company  and
the Holder.

           (d)  Consideration Other than Cash.  In the event that
Dilutive  Securities or Exchangeable Securities were  issued  for
consideration  other than cash, the per share  amounts  paid  for
such  Dilutive  Securities or Exchangeable  Securities  shall  be
determined  jointly  by the Company and the Participation  Rights
Holder.

           (e)   Appraiser.  If the Company and the Participation
Rights  Holder are unable to reach agreement within a  reasonable
period  of time with respect to (i) the Market Price of  Unlisted
Securities,  or  (ii)  the per share amounts  paid  for  Dilutive
Securities  or  Exchangeable Securities issued for  consideration
other than cash, such Market Price or per share amounts paid,  as
the  case  may  be,  shall be determined by an appraiser  jointly
selected by the Company and the Participation Rights Holder.  The
determination of such appraiser shall be final and binding on the
Company  and  the  Participation Rights  Holder.   The  fees  and
expenses of such appraiser shall be paid for by the Company.

<PAGE> 3.17

      4.4   Prior  Percentage Interest.  A  Participation  Rights
Holder's "Prior Percentage Interest" for purposes of the Right of
Maintenance  is  the  ratio  of (a)  the  number  of  Registrable
Securities  held by such Participation Rights Holder  as  of  the
date  of such Maintenance Notice (as defined in Section 4.6) (the
"Notice  Date"),  to  (b) the difference between  (i)  the  total
number of shares of Common Stock of the Company (and other voting
securities  of  the Company, if any) outstanding  on  the  Notice
Date,  where  for such purposes all Warrant Shares  held  by  the
Investor   and  its  Majority  Owned  Subsidiaries   are   deemed
outstanding,  and  (ii) the total number of  Dilutive  Securities
issued since the later of the date of this Agreement or the  last
Notice  Date excluding any Maintenance Securities (defined below)
issued pursuant to the last Maintenance Notice.

      4.5   Maintenance Amount.  A Participation Rights  Holder's
"Maintenance Amount" with respect to any Maintenance Notice shall
equal  such  number  of  Maintenance Securities  as  shall  (upon
purchase  thereof  in  full by the Participation  Rights  Holder)
enable  such  Participation Rights Holder to maintain  its  Prior
Percentage  Interest on a fully-diluted basis.   As  an  example,
assume  that the Company had 10,000 shares outstanding,  and  the
Participation  Rights Holder holds 20% of such shares  (or  2,000
shares).   The Company first issues 400 shares to a  third  party
("Issuance  1"), an amount insufficient to trigger  a  Notice  of
Issuance pursuant to Section 4.6.  The Company then issues  4,600
shares  to a third party ("Issuance 2"), an amount sufficient  to
trigger  a  Notice of Issuance.  The Participation Rights  Holder
will   have  the  right  to  maintain  its  20%  interest   after
considering  Issuances 1 and 2 and the new shares issued  to  the
Participation  Rights Holder.  In this example, the Participation
Rights Holder will have the right to purchase an additional 1,250
shares,  thereby  resulting  in the Participation  Rights  Holder
holding  20% of the securities outstanding (3,250 shares  out  of
16,250 shares).

      4.6  Notice of Issuance.  Within fifteen (15) business days
of  each  anniversary of this Agreement, and within fifteen  (15)
business days of each issuance of Dilutive Securities which  when
cumulated  with all prior issuances of Dilutive Securities  since
the later of (i) the date of this Agreement, or (ii) the date  of
the  last  Notice  Date  (subsequent to which  the  Participation
Rights  Holder  has  had an opportunity to  purchase  Maintenance
Securities),  results  in  a five percent  (5%)  reduction  in  a
Participation  Rights  Holders' Prior  Percentage  Interest,  the
Company  shall  give to each Participation Rights Holder  written
notice  (the  "Maintenance  Notice")  describing  the  number  of
Dilutive Securities issued since such prior Notice Date  and  the
non-price  terms  upon  which the Company  issued  such  Dilutive
Securities, and the Maintenance Amount of Maintenance  Securities
that such Participation Rights Holder is entitled to purchase  as
a result of such issuances.

     4.7  Purchase of Maintenance Securities.  Each Participation
Rights  Holder shall have sixty (60) days from the receipt  of  a
Maintenance  Notice to elect to purchase up to such Participation
Rights Holder's Maintenance Amount of such Maintenance Securities
at  the  Purchase Price as defined in Section 4.3  and  upon  the
terms  and  conditions specified in the Maintenance Notice.   The
closing  of such purchase shall occur within ten (10) days  after
such  election  to purchase.  If any Participation Rights  Holder
fails  to  elect  to purchase such Participation Rights  Holder's
full Maintenance Amount of Maintenance Securities within such

<PAGE> 3.18

sixty  (60)  day  period, then such Participation  Rights  Holder
shall  forfeit the right hereunder to purchase that part  of  its
Maintenance Amount that it did not so elect to purchase.

      4.8   Termination.  The provisions of Sections 4.1  through
4.7  shall terminate with respect to the issuance of any Dilutive
Securities  by the Company after the date that the  Investor  and
its  Affiliates (as defined in Rule 144 under the Securities Act)
collectively hold less than the number of shares of the Company's
Common  Stock equal to ten percent (10%) of the number of  shares
of  the  Company's  Common  Stock  and  other  voting  securities
outstanding  immediately following the closing  of  the  Purchase
Agreement  minus  100 shares (such number to  be  proportionately
adjusted for stock splits, stock dividends and similar events).

5.   RIGHTS IN CORPORATE EVENTS.

     5.l  Corporate Event.

           (a)   A  "Corporate  Event"  shall  mean  any  of  the
following,  whether  accomplished through  one  or  a  series  of
related  transactions (a) the acquisition of all or substantially
all  the assets of the Company, (b) an acquisition of the Company
by  consolidation, merger, share purchase or exchange,  or  other
reorganization  or  transaction  in  which  the  holders  of  the
Company's  outstanding  voting stock immediately  prior  to  such
transaction  own, immediately after such transaction,  securities
representing less than fifty percent (50%) of the voting power of
the  corporation or other entity surviving such transaction,  and
(c)  any  other  transaction or series  of  related  transactions
(excluding  any exercise or exercises of the Warrant) that  would
result in a greater than thirty percent (30%) change in the total
outstanding  number of shares of Voting Stock (as defined  below)
of  the Company (other than any such change solely as a result of
a stock split, stock dividend or other recapitalization affecting
holders of Common Stock and other classes of voting securities of
the Company on a pro rata basis).

           (b)   The  Company  agrees that it  will  provide  the
Investor with detailed written notice of any offer from  a  third
party for a proposed Corporate Event within two (2) business days
of  the  date  the Company first becomes aware of such  offer  or
proposed  Corporate Event.  In addition, the Company agrees  that
it will provide the Investor, within two (2) business days of the
Company's becoming aware thereof, with detailed written notice of
any offer from a third party to acquire ten percent (10%) or more
of  the  Company's outstanding voting securities.   The  Investor
agrees  to keep the information contained in such notice strictly
confidential.

      5.2   Right of First Refusal  The Company agrees that prior
to entering into any agreement that contemplates the consummation
of,  or any transaction that would constitute, a Corporate Event,
the  Company  will present to the Investor in writing  the  final
terms  and  conditions of the proposed Corporate Event, including
without limitation the name of the other party or parties to  the
Corporate Event and a copy of the definitive agreements that  the
Company  is prepared to enter into with respect to such Corporate
Event (the "Corporate Event Agreement").  The Investor shall have
ten  (10) calendar days from the date of receipt of the Corporate
Event Agreement to deliver written notice to the Company agreeing
in  writing  to  enter  into an agreement  with  the  Company  on
substantially  the  same terms and conditions  specified  in  the
Corporate  Event  Agreement,  which  agreement  shall  call   for
completion within one hundred

<PAGE> 3.19

twenty  (120)  days from the date of delivery  of  the  Corporate
Event  Agreement (such 120-day period subject to  extensions  for
regulatory  compliance).  If the Investor fails to  so  agree  in
writing within such ten (10) business day period, for a period of
one  hundred twenty (120) days thereafter, the Company shall have
the  right to enter into the Corporate Event Agreement  with  the
party specified in such agreement.

      5.3   Termination of Rights.  The rights  of  the  Investor
under  Section 5.2 shall terminate with respect to any  Corporate
Event  consummated  after  the date that  the  Investor  and  its
Affiliates  (as  defined in Rule 144 under  the  Securities  Act)
collectively hold less than the number of shares of the Company's
Common  Stock equal to ten percent (10%) of the number of  shares
of  the  Company's  Common  Stock  and  other  voting  securities
outstanding  immediately following the closing  of  the  Purchase
Agreement  minus  100 shares (such number to  be  proportionately
adjusted for stock splits, stock dividends and similar events).

6.   ASSIGNMENT AND AMENDMENT.

      6.1   Assignment.  Notwithstanding anything herein  to  the
contrary:

           (a)   Information Rights.  The rights of the  Investor
under Section 1.1 are transferable to any Holder who acquires and
holds  at least 750,000 shares of Registrable Securities (subject
to  appropriate  adjustment  for  all  stock  splits,  dividends,
combinations, recapitalizations and the like where all holders of
the  Company's  Common Stock participate on a  pro  rata  basis);
provided,  however,  that no party may be  assigned  any  of  the
foregoing  rights unless the Company is given written  notice  by
the  assigning party at the time of such assignment  stating  the
name  and  address of the assignee and identifying the securities
of  the  Company  as  to which the rights in question  are  being
assigned;  and  provided  further that any  such  assignee  shall
receive  such  assigned  rights subject  to  all  the  terms  and
conditions  of  this Agreement, including without limitation  the
provisions  of this Section 6.  The rights of the Investor  under
Section 1.2 may not be assigned.

           (b)  Registration Rights.  The registration rights  of
the  Investor  under  Section 2 hereof may  be  assigned  to  any
Holder; provided, however, that no party may be assigned  any  of
the  foregoing rights unless the Company is given written  notice
by the assigning party at the time of such assignment stating the
name  and  address of the assignee and identifying the securities
of  the  Company  as  to which the rights in question  are  being
assigned;  and  provided  further that any  such  assignee  shall
receive  such  assigned  rights subject  to  all  the  terms  and
conditions  of  this Agreement, including without limitation  the
provisions of this Section 6.

           (c)   Rights  of  Participation and Maintenance.   The
rights of the Investor under Sections 3 and Section 4 hereof  may
be   assigned  only  to  a  subsidiary  of  which  the   Investor
beneficially owns, either directly or indirectly, at least 50% of
the  Total  Voting  Power  (as defined in  Section  8.1)  of  all
outstanding  voting  securities (a "Majority Owned  Subsidiary");
provided,  however  that  no party may be  assigned  any  of  the
foregoing  rights unless the Company is given written  notice  by
the  Investor at the time of such assignment stating the name and
address  of the assignee and identifying the securities  of  the;
Company as to which the rights in

<PAGE> 3.20

question  are being assigned; and provided further that any  such
assignee  shall receive such assigned rights subject to  all  the
terms and conditions of this Agreement.

           (d)   Rights On Corporate Events.  The rights  of  the
Investor  under Section 5 hereof may be assigned only  in  whole,
and  not  in  part,  and  only  to a Majority  Owned  Subsidiary;
provided,  however  that  no party may be  assigned  any  of  the
foregoing  rights unless the Company is given written  notice  by
the  Investor at the time of such assignment stating the name and
address  of  the  assignee; and provided further  that  any  such
assignee  shall receive such assigned rights subject to  all  the
terms and conditions of this Agreement.

      6.2   Amendment of Rights.  Any provision of this Agreement
may  be  amended and the observance thereof may be waived (either
generally or in a particular instance and either retroactively or
prospectively), only with the written consent of the Company  and
Investor  (or,  in  the case of an amendment  or  waiver  of  any
provision  of Section 2 hereof, only with the written consent  of
the  Company  and  the Holders of a majority of  the  Registrable
Securities  then  outstanding and entitled  to  the  registration
rights  set forth in Section 2 hereof).  Any amendment or  waiver
effected  in  accordance with this Section 6.2 shall  be  binding
upon  the  Investor,  each Holder, each  permitted  successor  or
assignee of such Investor or Holder and the Company.

7.   CONFIDENTIALITY.

      7.1   (a)  Except to the extent required by law or judicial
order  or except as provided herein, each party to this Agreement
will hold any of the other's Confidential Information (as defined
in  the next paragraph) in confidence and will: (i) use the  same
degree  of care to prevent unauthorized disclosure or use of  the
Confidential Information that the receiving party uses  with  its
own  information  of  like nature (but  in  no  event  less  than
reasonable  care),  (ii)  limit disclosure  of  the  Confidential
Information,  including any materials regarding the  Confidential
Information that the receiving party has generated,  to  such  of
its  employees  and  contractors as  have  a  need  to  know  the
Confidential  Information  to accomplish  the  purposes  of  this
Agreement, and (iii) advise its employees, agents and contractors
of the confidential nature of the Confidential Information and of
the receiving party's obligations under this Agreement.

            (b)    For  purposes  of  this  Agreement,  the  term
"Confidential Information" refers to this Agreement, the  Warrant
and the Purchase Agreement (collectively, the "Agreements").  Any
employee  or contractor of the receiving party having  access  to
the  Confidential Information will be required  to  sign  a  non-
disclosure  agreement protecting the Confidential Information  if
not already bound by such a non-disclosure agreement.

      7.2  Except to the extent required by law or judicial order
or  except  as provided herein, neither party shall disclose  the
Agreements  or  any  of  their terms without  the  other's  prior
written   approval,  which  approval  will  not  be  delayed   or
unreasonably withheld.  Either party may disclose the  Agreements
to the extent required by law or judicial order, provided that if
such disclosure is pursuant to judicial order or proceedings, the
disclosing party will notify the other party promptly before such
disclosure  and  will  cooperate with the  other  party  to  seek
confidential   treatment  with  respect  to  the  disclosure   if
requested  by the other party and provided further that  if  such
disclosure  is required pursuant to the rules and regulations  of
any federal, state or local

<PAGE> 3.21

organization,  the  parties will cooperate to  seek  confidential
treatment of this Agreement to the maximum extent possible  under
law.

      7.3   Prior to the execution of the Agreements, the parties
will agree on the content of a joint press release announcing the
existence  of this Agreement, which press release will be  issued
as mutually agreed by the parties.

     7.4  Neither party will be required to disclose to the other
any  confidential information of any third party  without  having
first obtained such third party's prior written consent.

      7.5  The provisions of Sections 7.1, 7.2, 7.3 and 7.4 shall
survive  for a period of five (5) years from the date  which  the
Investor ceases to have any rights under Sections 1, 3, 4  and  5
of this Agreement.

      7.6   All other confidential information exchanged  by  the
parties    will    be   disclosed   pursuant   to    the    Intel
Corporation/Standard  Microsystems  Corporation  Corporate   Non-
Disclosure Agreement # 93761.

8.   STANDSTILL AGREEMENT.

      8.1   Standstill.   The  Investor hereby  agrees  that  the
Investor  (together  with all Majority Owned Subsidiaries)  shall
not  acquire  beneficial  ownership (as  defined  in  Rule  13d-3
promulgated  under  the  Securities  Exchange  Act  of  1934,  as
amended)  of any Voting Stock (as defined below), any  securities
convertible into or exchangeable for Voting Stock, or  any  other
right  to  acquire Voting Stock (except, in any case, by  way  of
stock   dividends  or  other  distributions  or  offerings   made
available  to holders of any Voting Stock generally) without  the
written consent of the Company, if the effect of such acquisition
would  be to increase the Voting Power (as defined below) of  all
Voting  Stock then beneficially owned (as defined above)  by  the
Investor  or which it has a right to acquire (together  with  all
Majority Owned Subsidiaries) to a percentage greater than twenty-
five  percent  (25%) (the "Standstill Percentage") of  the  Total
Voting  Power (as defined below) of the Company at  the  time  in
effect; provided that nothing in this Section 8 shall affect  the
Investors rights under Section 5, and provided further that:

           (a)   The  Investor may acquire Voting  Stock  without
regard to the foregoing limitation, and such limitation shall  be
suspended, but not terminated, if and for as long as (i) a tender
or  exchange offer is made and is not withdrawn or terminated  by
another person or group to purchase or exchange for cash or other
consideration any Voting Stock that, if accepted or if  otherwise
successful,  would  result in such person or  group  beneficially
owning or having the right to acquire shares of Voting Stock with
aggregate Voting Power of more than thirty percent (30%)  of  the
Total  Voting  Power of the Company then in effect (not  counting
for  these  purposes any shares of Voting Stock  of  the  Company
originally acquired ( where such Shares or shares exchanged  with
the Company in respect thereof, are still held) by such person or
group  from  the Investor or any Majority Owned Subsidiary),  and
such  offer is not withdrawn or terminated prior to the  Investor
making  an  offer  to  acquire Voting Stock or  acquiring  Voting
Stock;   provided,   however,  that  the   foregoing   standstill
limitation  will be reinstated once any such tender  or  exchange
offer  is  withdrawn or terminated, (ii) another person or  group
hereafter acquires Voting

<PAGE> 3.22

Stock  with  aggregate Voting Power of more than  twenty  percent
(20%)  of  the Total Voting Power of the Company then  in  effect
(not  counting for these purposes any shares of Voting  Stock  of
the  Company  originally acquired (where such  Shares  or  shares
exchanged with the Company in respect thereof, are still held) by
such  person  or  group from the Investor or any  Majority  Owned
Subsidiary),  where  such person or group files  a  Schedule  13D
(under  the  rules  promulgated under  Section  13(d)  under  the
Securities  and Exchange Act of 1934, as such rules  and  section
are  in effect on the date hereof), or other similar or successor
schedule  or  form,  indicating that  such  person's  or  group's
holdings exceed twenty percent (20%); provided, however, that the
foregoing  standstill  limitation will  be  reinstated  once  the
percentage of Total Voting Power beneficially owned by such other
person  or group falls below twenty percent (20%); (iii)  another
person  or group hereafter acquires Voting Stock that results  in
such  person or group being required to file a Schedule  13G,  or
other similar or successor schedule or form, indicating that such
other  person  or  group beneficially owns or has  the  right  to
acquire  Voting Stock with aggregate Voting Power  of  more  than
twenty-five  percent  (25%)  of the Total  Voting  Power  of  the
Company  (not  counting for these purposes any shares  of  Voting
Stock  of  the Company originally acquired (where such Shares  or
shares  exchanged with the Company in respect thereof, are  still
held)  by  such person or group from the Investor or any Majority
Owned   Subsidiary);  provided,  however,  that   the   foregoing
standstill  limitation will be reinstated once the percentage  of
Total  Voting  Power beneficially owned by such other  person  or
group  falls  below twenty-five percent (25%);  or  (iv)  another
credible  person  or  group orally or  in  writing  contacts  the
Company  and  advises  the Company of such person's   or  group's
intention  to  commence a tender or exchange offer  that,  if  so
commenced,  would result in a suspension pursuant to  clause  (i)
above  (e.g.,  a "bear hug" offer); provided, however,  that  the
foregoing  standstill  limitation  will  be  reinstated  if  such
intention is withdrawn in writing or other reasonable evidence of
such  withdrawal is provided to the Investor.  The Company  shall
notify  the  Investor in writing of the occurrence of  any  event
described   in  clauses  (i)  through  (iv)  of  the  immediately
preceding sentence as soon as practicable following the Company's
becoming aware of any such event, and in any case, shall  provide
the  Investor  written notice of any such event  within  two  (2)
business  days of the Company's being aware of the occurrence  of
any such event.

          (b)  The Investor will not be obliged to dispose of any
Voting  Stock to the extent that the aggregate percentage of  the
Total  Voting  Power of the Company represented by  Voting  Stock
beneficially  owned by the Investor or which the Investor  has  a
right  to  acquire is increased beyond the Standstill  Percentage
(i)  as  a  result  of a recapitalization of  the  Company  or  a
repurchase or exchange of securities by the Company or any  other
action taken by the Company or its affiliates; (ii) as the result
of  acquisitions of Voting Stock made during the period when  the
Investor's  "standstill" obligations are  suspended  pursuant  to
Section 8.1(a); (iii) as a result of an equity index transaction,
provided that Investor shall not vote such shares; (iv) by way of
stock  dividends  or other distributions or rights  or  offerings
made  available  to holders of shares of Voting Stock  generally;
(v)  with  the  consent of a simple majority of  the  independent
authorized members of the Company's Board of Directors;  or  (vi)
as  part of a transaction on behalf of Investor's Defined Benefit
Pension  Plan,  Profit  Sharing Retirement Plan,  401(k)  Savings
Plan,  Sheltered Employee Retirement Plan and Sheltered  Employee
Retirement  Plan Plus, or any successor or additional  retirement
plans thereto (collectively, the "Retirement

<PAGE> 3.23

Plans")  where the Company's shares in such Retirement Plans  are
voted by a trustee for the benefit of Investor employees or,  for
those  Retirement  Plans  where Investor controls  voting,  where
Investor  agrees  not to vote any shares of such Retirement  Plan
Voting  Stock that would cause Investor to exceed the  Standstill
Percentage.

           (c)   As  used in this Section 8, (i) the term "Voting
Stock" means the Common Stock and any other securities issued  by
the Company having the ordinary power to vote in the election  of
directors of the Company (other than securities having such power
only  upon the happening of a contingency that has not occurred),
(ii) the term "Voting Power" of any Voting Stock means the number
of  votes such Voting Stock is entitled to cast for directors  of
the  Company  at any meeting of shareholders of the Company,  and
(iii)  the  term "Total Voting Power" means the total  number  of
votes  which  may  be cast in the election of  directors  of  the
Company  at  any  meeting of shareholders of the Company  if  all
Voting  Stock  was  represented and voted to the  fullest  extent
possible at such meeting, other than votes that may be cast  only
upon  the happening of a contingency that has not occurred.   For
purposes  of this Section 8, the Investor shall not be deemed  to
have  beneficial ownership of any Voting Stock held by a  pension
plan  or  other employee benefit program of the Investor  if  the
Investor  does  not  have  the power to  control  the  investment
decisions of such plan or program.

      8.2  Right of First Refusal upon Section 8.1(a) Event.   If
the   Investor  or  any  Majority  Owned  Subsidiary  elects   to
participate and tender or exchange any of the Shares, the Warrant
and/or  the  Warrant  Shares pursuant to any event  described  in
clause  (i) of the first sentence of Section 8.1(a), the Investor
shall  provide written notice of such intention to  the  Company.
The  Company  shall have five (5) business days from delivery  of
such  notice to elect to purchase all, but not less than all,  of
such  Shares  from the Investor or Majority Owned Subsidiary  for
cash, at the Offer Price (as defined below) per share offered  by
the  person  or  group in the event described in clause  (i),  by
delivering  an  irrevocable written election by  the  Company  to
purchase  such  Shares at such price.  In the event  the  Company
delivers such written election, the Company shall be obligated to
purchase, and the Investor or Majority Owned Subsidiary shall  be
obligated to sell, such Shares within ten (10) business  days  of
delivery  of the Company's written election to the Investor.   If
the  Company  fails to deliver such written election  within  the
five (5) business day period described above or fails to purchase
such  Shares  within the ten (10) business day  period  described
above,  it shall forfeit its rights under this Section  8.2  with
respect to such tender or exchange, regardless whether the  terms
and  conditions  of such tender or exchange may  subsequently  be
modified.  As used herein, "Offer Price" means (a) in the case of
a cash offer, the amount of cash per share to be paid; (b) in the
case  of a share offer where the shares offered are listed on  an
exchange or quoted on the Nasdaq National Market, an amount equal
to  the average of the closing prices of such security's sales on
all  domestic securities exchanges on which said security may  at
the  time be listed, or, if there have been no sales on any  such
exchange  on such day, the average of the highest bid and  lowest
asked prices on all such exchanges at the end of such day, or, if
on  any  day such security is not so listed, the average  of  the
representative bid and asked prices quoted in the NASDAQ National
Market  as  of 4:00 p.m., New York time, or, if on any  day  such
security is not quoted in the NASDAQ National Market, the average
of  the  highest bid and lowest asked prices on such day  in  the
domestic

<PAGE> 3.24

over-the-counter  market as reported by  the  National  Quotation
Bureau, Incorporated, or any similar successor organization,  all
determined  as  of  the date written notice is delivered  to  the
Company  by the Investor pursuant to the first sentence  of  this
Section  8.2; or (c) in the event of any other tender or exchange
offer,  the value of the securities and/or other property as  set
forth in the offer by the person or group making such offer.

      8.3   Right  of First Refusal.  If the Investor intends  to
sell,  in a Privately Negotiated Transaction (as defined  below),
Voting  Stock (including the Voting Stock underlying any  portion
of  the  Warrants proposed to be sold) constituting one-third  or
more  of  the Voting Stock (including the Voting Stock underlying
any  such portion of the Warrant) held by the Investor (but  only
if  the number of Shares proposed to be sold is greater than  one
percent (1%) of the Company's Voting Stock then outstanding), the
Investor shall provide written notice thereof to the Company (the
"Investor Notice"). The Investor Notice shall specify the  number
of  Shares  involved and the proposed price  per  Share.   For  a
period  of ten (10) business days after delivery of the  Investor
Notice,  the Company shall be entitled to elect to purchase  all,
but  not  less than all, of the Shares described in the  Investor
Notice,  at  the  price per share described in  such  notice,  by
delivery  of a written notice (a "Company Purchase Election")  to
the  Investor  irrevocably electing to purchase such  Shares  and
shall  have thirty (30) business days to consummate said purchase
from  the  Investor.   In  the event that  the  Company  has  not
delivered a Company Purchase Election prior to the expiration  of
such  ten (10) business-day period or has failed to purchase such
Shares within said thirty (30) business day period, the Company's
right  to purchase such Shares shall expire, and the Investor  or
Majority  Owned Subsidiary shall be entitled to sell  the  Shares
described in the Investor Notice for a period of sixty (60)  days
following  the expiration of such 60-day period, but only  for  a
purchase  price equal to at least one-hundred percent  (100%)  of
the  purchase  price set forth in the Investor  Notice.   In  the
event the Investor or Majority Owned Subsidiary has not sold such
Shares  by  the  end  of such 60-day period, the  rights  of  the
Company  set forth above in this Section 8.3 shall apply  to  any
subsequent  sales  by the Investor or Majority Owned  Subsidiary.
Notwithstanding the foregoing, the provisions of this Section 8.3
shall  not apply to any sales or other transfers by the  Investor
to  any  Majority Owned Subsidiary.  As used herein, a "Privately
Negotiated  Transaction"  means a sale  by  the  Investor  to  an
unrelated  third party in which the Investor and the third  party
have directly negotiated the price and terms of such sale.

      8.4  Termination of Standstill.  The provisions of Sections
8.1  through  8.3 shall terminate on earlier of:  (a)  the  tenth
anniversary of the date of this Agreement; or (b) the  date  when
the  Investor  (together  with all Majority  Owned  Subsidiaries)
ceases  to  beneficially own at least five percent  (5%)  of  the
Total  Voting Power of the Company; provided, however,  that  for
purposes  of  determining  beneficial ownership,  the  number  of
Warrant  Shares underlying the unexercised portion of the Warrant
shall be included.

      8.5   Other Agreements.  The Company agrees to require  any
other  purchaser  of newly issued Company securities  (including,
but  not limited to, warrants and options) representing at  least
ten  percent (10%) of the voting power of the Company, on  an  as
converted  basis, to enter into terms at least as restrictive  to
such purchaser as those contained in this Section 8.

<PAGE> 3.25

9.   GENERAL PROVISIONS.

      9.1   Notices.  Any notice required or permitted under this
Agreement  will  be  given in writing, shall  be  effective  when
received,  and  shall  in  any  event  be  deemed  received   and
effectively  given  upon personal delivery to  the  party  to  be
notified or three (3) business days after deposit with the United
States  Post  Office,  by registered or certified  mail,  postage
prepaid,  or one (1) business day after deposit with a nationally
recognized  courier service such as Fedex for next  business  day
delivery,  or  one  (1) business day after  facsimile  with  copy
delivered  by registered or certified mail, postage  prepaid  and
addressed  to  the party to be notified at the address  indicated
for  such  party on the signature page hereof or  at  such  other
address as the Investor or the Company may designate by giving at
least  ten  (10)  days advance written notice  pursuant  to  this
Section 10.1.

          (a) if to the Investor, at:  Intel Corporation
                                       2200 Mission College
                                       Blvd.
                                       Santa Clara, California
                                       95052-8119
                                       Attention:  Treasurer,
                                       M/S: SC4-210
              Telephone No.:           (408) 765-1240
              Facsimile No.:           (408) 765-8458
                                       and
                                       Attention:  General
                                       Counsel, M/S SC4-203
              Telephone No.:           (408) 765-1125
              Facsimile No.:           (408) 765-7636
                                       
              with a copy to:          Gibson, Dunn & Crutcher
                                       LLP
                                       One Montgomery Street
                                       Telesis Tower
                                       San Francisco, California
                                       94104-4505
                                       Attention:  Kenneth R.
                                       Lamb
              Telephone No.:           (415) 393-8382
              Facsimile No.:           (415) 986-5309
                                       
          (b) if to the Company, at:   Standard Microsystems
                                       Corporation
                                       80 Arkay Drive
                                       Hauppauge, New York 11788
                                       Attention:  Chairman and
                                       CEO
              Telephone No.:           (516) 434-2803
              Facsimile No.:           (516) 273-5550
                                       
              with a copy to:          Loeb & Loeb L.L.P.
                                       345 Park Avenue
                                       New York, New York 10154-
                                       0037
                                       Attention:  David C.
                                       Fischer, Esq.
              Telephone No.:           (212) 407-4827
              Facsimile No.:           (212) 407-4990
                                       
<PAGE> 3.26

Any  party  hereto (and such party's permitted  assigns)  may  by
notice  so given change its address for future notices hereunder.
Notice  shall  conclusively be deemed to  have  been  given  when
personally delivered or when deposited in the mail in the  manner
set  forth  above.   Any  notice  provided  to  the  Investor  in
accordance  with this Section 10.1 shall be deemed to  have  also
been  given  to  any Majority Owned Subsidiary,  and  any  notice
provided  by  the Investor to the Company shall  also  be  deemed
notice  by  its  Majority Owned Subsidiaries, and they  shall  be
bound thereby.

      9.2   Entire Agreement.  This Agreement, together with  all
the   Exhibits  hereto,  constitutes  and  contains  the   entire
agreement  and understanding of the parties with respect  to  the
subject   matter  hereof  and  supersedes  any  and   all   prior
negotiations, correspondence, agreements, understandings,  duties
or  obligations between the parties respecting the subject matter
hereof.

     9.3  Governing Law.  This Agreement shall be governed by and
construed exclusively in accordance with the internal laws of the
State  of  Delaware,  excluding that  body  of  law  relating  to
conflict of laws and choice of law.

      9.4   Severability.   If  one or more  provisions  of  this
Agreement are held to be unenforceable under applicable law, then
such  provision(s) shall be excluded from this Agreement and  the
balance  of  this  Agreement  shall be  interpreted  as  if  such
provision(s)  were  so  excluded  and  shall  be  enforceable  in
accordance with its terms.

      9.5  Third Parties.  Nothing in this Agreement, express  or
implied,  is intended to confer upon any person, other  than  the
parties  hereto and their permitted successors and  assigns,  any
rights or remedies under or by reason of this Agreement.

      9.6  Successors And Assigns.  Subject to the provisions  of
Section 6.1, the provisions of this Agreement shall inure to  the
benefit  of,  and  shall  be  binding upon,  the  successors  and
permitted assigns of the parties hereto.

      9.7   Captions.  The captions to sections of this Agreement
have been inserted for identification and reference purposes only
and shall not be used to construe or interpret this Agreement.

      9.8   Counterparts.   This Agreement  may  be  executed  in
counterparts, each of which shall be deemed an original, but  all
of which together shall constitute one and the same instrument.

      9.9   Adjustments for Stock Splits, Etc.  Wherever in  this
Agreement there is a reference to a specific number of shares  of
Common  Stock  of the Company, then, upon the occurrence  of  any
subdivision, combination or stock dividend of Common  Stock,  the
specific  number of shares so referenced in this Agreement  shall
automatically be proportionally adjusted to reflect the affect on
the  outstanding shares of such class or series of stock by  such
subdivision, combination or stock dividend.

<PAGE> 3.27

      9.10  Competition.  Nothing set forth  herein,  or  in  the
Purchase Agreement or Warrant, shall be deemed to preclude, limit
or  restrict the Company's or the Investor's ability  to  compete
with the other.

    [The remainder of this page is intentionally left blank.]
                                
<PAGE> 3.28

IN  WITNESS  WHEREOF,  the  parties  hereto  have  executed  this
Agreement as of the date and year first above written.

STANDARD MICROSYSTEMS               INTEL CORPORATION
CORPORATION
                                    
By:  _______________________        By:  _______________________
                                    
Name:  _____________________        Name:  _____________________
                                    
Title:  ____________________        Title:  ____________________
                                    
          [Signature Page to Investor Rights Agreement]
                                






                         EXHIBIT 4
                              
<PAGE> 4.1
                      PRESS RELEASE OF
             STANDARD MICROSYSTEMS CORPORATION
                              
 STANDARD MICROSYSTEMS ANNOUNCES INTEL EQUITY INVESTMENT AS
 THE TWO COMPANIES AGREE TO COOPERATE IN THE DEVELOPMENT OF
  NEXT-GENERATION INPUT/OUTPUT COMPONENTS FOR THE PERSONAL
                      COMPUTER INDUSTRY
                              
HAUPPAUGE,  N.Y.  (March  18,  1997)--Standard  Microsystems
Corporation   (NASDAQ:SMSC)  announced  today   that   Intel
Corporation  of  Santa Clara, California  (NASDAQ:INTC)  has
entered  into  agreements  with  Standard  Microsystems,   a
supplier    of   leading-edge   input/output   semiconductor
integrated  circuits.   Intel  will  also  make  an   equity
investment  in Standard Microsystems.  Under  the  terms  of
agreements  recently  signed by  the  companies,  Intel  and
Standard  Microsystems  will  work  cooperatively   on   the
integration   of   new   semiconductor  input/output   (I/O)
integrated  circuits, which have been specifically  designed
to  work with Intel's latest microprocessors and core  logic
chip sets, into selected Intel personal computer motherboard
designs  through  the end of 1997.  The two  companies  have
also agreed to cooperate on a family of proprietary low-pin-
count I/O devices for future applications.

Standard Microsystems expects to supply these I/O integrated
circuit  components to customers around the world, including
Intel's  own personal computer motherboard division, Intel's
motherboard   licensees   and   major   personal    computer
manufacturers.    As   a   result,   Standard   Microsystems
anticipates that the total amount of business that  it  will
do with Intel and Intel's licensees should increase.

Under  the agreements, Intel will purchase just under a  10%
interest   in  Standard  Microsystems  Corporation,   buying
approximately  1,540,000  shares of  Standard  Microsystems'
common  stock directly from the Company at a price of  $9.50
per share.  Intel will also receive warrants to purchase  an
additional 10% interest in Standard Microsystems and certain
anti-dilutive rights.

Speaking  for  Standard Microsystems Corporation,  Mr.  Paul
Richman,  the  Company's Chairman of  the  Board  and  Chief
Executive Officer, indicated that "Over the past few  years,
despite  intense  competition,  Standard  Microsystems   has
become  one  of  the  leading architects  and  suppliers  of
input/output  circuits  to the worldwide  personal  computer
industry.  We have always had a very good relationship  with
Intel,  a company that I personally have an enormous  amount
of  respect for, and this new cooperative effort  with  them
should  help  us  considerably in our efforts  to  establish
Standard  Microsystems'  advanced  input/output  devices  as
worldwide  industry standards.  We look forward  to  working
more  closely  with Intel in this and other areas  over  the
years ahead."

Standard Microsystems Corporation (NASDAQ:SMSC) is based  in
Hauppauge,  New  York  and has offices worldwide,  including
locations  in North America, Australia, Asia, Europe,  Japan
and   Latin   America.   Standard  Microsystems'   Component
Products  Division  supplies metal-oxide-semiconductor/very-
large-scale-integrated  (MOS/VLSI)  circuit  components  for
personal  computers, local area networks (LANs)and  embedded
control  systems.   The Company's System  Products  Division
provides  a broad range of networking solutions for scaling,
managing  and connecting local area networks, including  LAN
adapters,  LAN  hubs,  LAN switches and  network  management
software.    Additional  information   concerning   Standard
Microsystems Corporation is available from its site  on  the
World Wide Web at http://www.smc.com

"Safe   Harbor"  Statement  under  the  Private   Securities
Litigation  Reform  Act  of  1995:   Except  for  historical
information contained herein, the matters discussed in  this
announcement  are  forward-looking statements  that  involve
risks  and  uncertainties, including the timely  development
and  market  acceptance  of  new  products,  the  impact  of
competitive  products and pricing, the  effect  of  changing
economic conditions, and such risks and uncertainties as are
detailed  from  time to time in the company's  SEC  reports,
including  the  Annual Report filed on  Form  10-K  and  the
Quarterly Reports filed on Form 10-Q.



E0021E.DOC/3-25-97
                          EXHIBIT 5
                               
<PAGE> 5.1
                     SIGNATURE AUTHORITY
                               

[INTEL CORPORATE ADDRESS]

[INTEL LOGO]


March 7, 1997





TO WHOM IT MAY CONCERN:

I  will be out of the office on sabbatical from Monday,  March
10  through  Tuesday, May 6, 1997.  In my  absence,  Peter  N.
Detkin,  Director  of  Litigation, will  have  full  signature
authority.

Sincerely,

/s/F. Thomas Dunlap, Jr.        
- --------------------------
F. Thomas Dunlap, Jr.
Vice President, General Counsel & Secretary












© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission